| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYH2 MYH3 SYNPO2 MYH9 MYH11 SPTAN1 GAS8 PANX1 ACTN2 MRTFB BRCA2 SCN5A DIAPH2 MICAL3 KIF5B KIF5C GNAS MICAL1 MAP7D3 KIF21A USH1C KIF7 BICDL1 EEF2 SLC8A1 SBDS MACF1 MARK2 ARHGEF2 CTTN SNX5 MYBPC1 KIF1C | 2.39e-08 | 1099 | 204 | 33 | GO:0008092 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | MYH2 MYH3 MYH9 MYH11 KIF5B KIF5C DNAH8 KIF21A DNAH2 KIF7 KIF1C | 3.56e-08 | 118 | 204 | 11 | GO:0003774 |
| GeneOntologyMolecularFunction | ribosomal protein S6 kinase activity | 3.61e-07 | 7 | 204 | 4 | GO:0004711 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH2 MYH3 ABCA1 MYH9 MYH11 ATP6V0A1 SMC1A DHX38 PSMC1 ATAD3C KIF5B KIF5C DNAH8 ATP8B3 KIF21A DNAH2 SMC4 KIF7 ERCC6L2 MACF1 KIF1C | 1.40e-06 | 614 | 204 | 21 | GO:0140657 |
| GeneOntologyMolecularFunction | chromatin binding | RNF168 SMC1A NEUROD1 HOXD10 MCM3AP CDYL NKAP MED12 SMC4 XBP1 SKI DNAJC2 MSGN1 KAT7 SF3B1 SMARCD1 SMARCD2 SMARCD3 CDCA5 HES5 STAG2 TRIM37 L3MBTL4 | 2.14e-06 | 739 | 204 | 23 | GO:0003682 |
| GeneOntologyMolecularFunction | microtubule motor activity | 7.29e-06 | 70 | 204 | 7 | GO:0003777 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | MYH3 ABCA1 SMC1A DHX38 PSMC1 ATAD3C KIF5B KIF5C DNAH8 ATP8B3 KIF21A DNAH2 SMC4 KIF7 MACF1 KIF1C | 1.29e-05 | 441 | 204 | 16 | GO:0016887 |
| GeneOntologyMolecularFunction | actin filament binding | MYH2 MYH3 MYH9 MYH11 SPTAN1 PANX1 ACTN2 MICAL1 EEF2 MACF1 CTTN | 2.29e-05 | 227 | 204 | 11 | GO:0051015 |
| GeneOntologyMolecularFunction | calmodulin binding | MYH2 MYH3 MYH9 MYH11 SPTAN1 SCN5A UBR4 SLC8A1 SLC8A3 PPP3CB PPP3CC | 2.58e-05 | 230 | 204 | 11 | GO:0005516 |
| GeneOntologyMolecularFunction | actin binding | MYH2 MYH3 SYNPO2 MYH9 MYH11 SPTAN1 PANX1 ACTN2 MRTFB DIAPH2 MICAL3 MICAL1 EEF2 MACF1 CTTN MYBPC1 | 3.53e-05 | 479 | 204 | 16 | GO:0003779 |
| GeneOntologyMolecularFunction | cadherin binding | MYH9 SLK SPTAN1 MRTFB KIF5B SH3GL1 EEF2 STXBP6 MACF1 MARK2 CTTN SNX1 SNX5 | 4.87e-05 | 339 | 204 | 13 | GO:0045296 |
| GeneOntologyMolecularFunction | monoatomic ion antiporter activity involved in regulation of postsynaptic membrane potential | 1.04e-04 | 2 | 204 | 2 | GO:0099580 | |
| GeneOntologyMolecularFunction | calcium:monoatomic cation antiporter activity involved in regulation of postsynaptic cytosolic calcium ion concentration | 3.10e-04 | 3 | 204 | 2 | GO:1905060 | |
| GeneOntologyMolecularFunction | histone H3 acetyltransferase activity | 4.37e-04 | 15 | 204 | 3 | GO:0010484 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 5.95e-04 | 38 | 204 | 4 | GO:0000146 | |
| GeneOntologyMolecularFunction | plus-end-directed microtubule motor activity | 6.43e-04 | 17 | 204 | 3 | GO:0008574 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | SYNPO2 ZMYND11 MYH9 ACTN2 ALKBH5 MRTFB CDYL MICAL3 NKAP MED12 WWC1 PRAMEF11 PRAMEF6 CUL1 COL19A1 SKI DNAJC2 MED15 KAT7 KLHL25 SNW1 STEEP1 SMARCD1 SMARCD2 SMARCD3 CNOT1 TRIM37 | 6.68e-04 | 1356 | 204 | 27 | GO:0060090 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | SYNPO2 ZMYND11 MYH9 ACTN2 ALKBH5 MRTFB CDYL MED12 WWC1 PRAMEF11 PRAMEF6 CUL1 COL19A1 SKI DNAJC2 MED15 KAT7 KLHL25 SNW1 STEEP1 SMARCD1 SMARCD2 SMARCD3 TRIM37 | 8.00e-04 | 1160 | 204 | 24 | GO:0030674 |
| GeneOntologyMolecularFunction | G-protein alpha-subunit binding | 9.56e-04 | 43 | 204 | 4 | GO:0001965 | |
| GeneOntologyMolecularFunction | calmodulin-dependent protein phosphatase activity | 1.02e-03 | 5 | 204 | 2 | GO:0033192 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | MYH3 ABCA1 SMC1A DHX38 PSMC1 ATAD3C KIF5B KIF5C GNAS DNAH8 ATP8B3 KIF21A DNAH2 SMC4 KIF7 EEF2 MACF1 KIF1C | 1.04e-03 | 775 | 204 | 18 | GO:0017111 |
| GeneOntologyMolecularFunction | N-acetyltransferase activity | 1.22e-03 | 78 | 204 | 5 | GO:0008080 | |
| GeneOntologyMolecularFunction | microtubule binding | GAS8 KIF5B KIF5C MAP7D3 KIF21A KIF7 SBDS MACF1 ARHGEF2 KIF1C | 1.31e-03 | 308 | 204 | 10 | GO:0008017 |
| GeneOntologyMolecularFunction | protein serine kinase activity | SMG1 SLK TRIO RPS6KA1 RPS6KA2 RPS6KA3 TLK1 RPS6KA6 KALRN MARK2 MAPK4 | 1.32e-03 | 363 | 204 | 11 | GO:0106310 |
| GeneOntologyMolecularFunction | histone H2A ubiquitin ligase activity | 1.52e-03 | 6 | 204 | 2 | GO:0141053 | |
| GeneOntologyMolecularFunction | tubulin binding | GAS8 BRCA2 KIF5B KIF5C GNAS MAP7D3 KIF21A KIF7 SBDS MACF1 ARHGEF2 KIF1C | 1.56e-03 | 428 | 204 | 12 | GO:0015631 |
| GeneOntologyMolecularFunction | myosin phosphatase activity | 1.79e-03 | 85 | 204 | 5 | GO:0017018 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 1.82e-03 | 51 | 204 | 4 | GO:0004402 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | ZMYND11 ACTN2 MRTFB CDYL MED12 WWC1 SKI MED15 KAT7 SNW1 SMARCD1 SMARCD2 SMARCD3 TRIM37 | 1.98e-03 | 562 | 204 | 14 | GO:0003712 |
| GeneOntologyMolecularFunction | gap junction hemi-channel activity | 2.11e-03 | 7 | 204 | 2 | GO:0055077 | |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 2.40e-03 | 55 | 204 | 4 | GO:0042974 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 2.40e-03 | 55 | 204 | 4 | GO:0061733 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | MYH3 ABCA1 SMC1A DHX38 PSMC1 ATAD3C KIF5B KIF5C GNAS DNAH8 ATP8B3 KIF21A DNAH2 SMC4 KIF7 EEF2 MACF1 KIF1C | 2.48e-03 | 839 | 204 | 18 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | MYH3 ABCA1 SMC1A DHX38 PSMC1 ATAD3C KIF5B KIF5C GNAS DNAH8 ATP8B3 KIF21A DNAH2 SMC4 KIF7 EEF2 MACF1 KIF1C | 2.51e-03 | 840 | 204 | 18 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | MYH3 ABCA1 SMC1A DHX38 PSMC1 ATAD3C KIF5B KIF5C GNAS DNAH8 ATP8B3 KIF21A DNAH2 SMC4 KIF7 EEF2 MACF1 KIF1C | 2.51e-03 | 840 | 204 | 18 | GO:0016818 |
| GeneOntologyMolecularFunction | scaffold protein binding | 2.66e-03 | 93 | 204 | 5 | GO:0097110 | |
| GeneOntologyMolecularFunction | calcium-dependent protein serine/threonine phosphatase activity | 2.79e-03 | 8 | 204 | 2 | GO:0004723 | |
| GeneOntologyBiologicalProcess | microtubule-based process | MYH9 SLK SMC1A GAS8 FYCO1 PTEN BRCA2 CFAP45 KIF5B KIF5C DNAH8 HTR1A MAP7D3 KIF21A DNAH2 MAP7 CCDC57 KIF7 BICDL1 SBDS CEP250 CFAP58 MACF1 MARK2 ARHGEF2 CFAP44 STAG2 TRIM37 KIF1C | 4.64e-07 | 1058 | 201 | 29 | GO:0007017 |
| GeneOntologyBiologicalProcess | DNA repair | SMG1 RNF168 SMC1A TRAIP PAGR1 BCL7A BRCA2 ETAA1 ASCC2 PDS5A TIMELESS SMC4 GINS4 NSMCE2 KAT7 ERCC6L2 SMARCD1 SMARCD2 SMARCD3 CDCA5 TOP3A | 1.56e-06 | 648 | 201 | 21 | GO:0006281 |
| GeneOntologyBiologicalProcess | stem cell population maintenance | SMC1A BCL7A NKAP MED12 PRAMEF11 PRAMEF6 SKI MED15 SMARCD1 CNOT1 HES5 STAG2 | 3.85e-06 | 237 | 201 | 12 | GO:0019827 |
| GeneOntologyBiologicalProcess | maintenance of cell number | SMC1A BCL7A NKAP MED12 PRAMEF11 PRAMEF6 SKI MED15 SMARCD1 CNOT1 HES5 STAG2 | 4.77e-06 | 242 | 201 | 12 | GO:0098727 |
| GeneOntologyBiologicalProcess | anterior/posterior pattern specification | CYP26A1 HOXA10 NEUROD1 HOXD10 PDS5A MED12 HES3 SKI MSGN1 SF3B1 DMRT2 HES5 | 5.88e-06 | 247 | 201 | 12 | GO:0009952 |
| GeneOntologyBiologicalProcess | protein-containing complex disassembly | MYH9 SPTAN1 FYCO1 ACTN2 MICAL3 KIF5B MICAL1 HTR1A SH3GL1 SMARCD1 SMARCD2 SMARCD3 ARHGEF2 | 5.96e-06 | 291 | 201 | 13 | GO:0032984 |
| GeneOntologyBiologicalProcess | regulation of nucleotide-excision repair | 8.21e-06 | 29 | 201 | 5 | GO:2000819 | |
| GeneOntologyBiologicalProcess | embryo development | MYH3 MYH9 HOXA10 GJA5 NEUROD1 MRTFB BRCA2 HOXD10 RPS6KA6 PDS5A TIMELESS PLCG1 GNAS MED12 PRAMEF11 PRAMEF6 WNT7B DUSP5 GINS4 HES3 SKI USH1C MSGN1 PALS1 SLC8A1 SF3B1 DMRT2 SBDS MACF1 SYVN1 CNOT1 HES5 | 9.53e-06 | 1437 | 201 | 32 | GO:0009790 |
| GeneOntologyBiologicalProcess | DNA damage response | SMG1 RNF168 SMC1A TRAIP PAGR1 BCL7A TLK1 BRCA2 ETAA1 RPS6KA6 ASCC2 PDS5A TIMELESS SMC4 GINS4 NSMCE2 KAT7 SNW1 ERCC6L2 SMARCD1 SMARCD2 SMARCD3 CDCA5 TOP3A | 2.24e-05 | 959 | 201 | 24 | GO:0006974 |
| GeneOntologyBiologicalProcess | mitotic sister chromatid cohesion | 2.47e-05 | 36 | 201 | 5 | GO:0007064 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | MYH9 SLK SMC1A GAS8 PTEN BRCA2 DNAH8 HTR1A MAP7D3 DNAH2 MAP7 CCDC57 SBDS CEP250 CFAP58 MARK2 ARHGEF2 CFAP44 STAG2 TRIM37 | 2.66e-05 | 720 | 201 | 20 | GO:0000226 |
| GeneOntologyBiologicalProcess | muscle tissue development | MYH11 HLF ACTN2 PTEN GJA5 FBXO22 MRTFB HOXD10 SCN5A CACNA1G TAFAZZIN COL19A1 SKI CREB1 SLC8A1 SNW1 PPP3CB | 3.53e-05 | 558 | 201 | 17 | GO:0060537 |
| GeneOntologyBiologicalProcess | cellular component disassembly | MYH9 SPTAN1 FYCO1 ACTN2 ASCC2 MICAL3 KIF5B TAFAZZIN MICAL1 HTR1A SH3GL1 NEMF SMARCD1 SMARCD2 SMARCD3 MARK2 ARHGEF2 CTTN | 3.64e-05 | 617 | 201 | 18 | GO:0022411 |
| GeneOntologyBiologicalProcess | regulation of anatomical structure size | MYH9 SPTAN1 ACTN2 PTEN ADCY6 GJA5 GCLC CACNA1G PLEKHA7 HTR1A DEPTOR WNT7B DUSP5 USH1C CREB1 SLC8A1 MACF1 CTTN | 3.72e-05 | 618 | 201 | 18 | GO:0090066 |
| GeneOntologyBiologicalProcess | membrane depolarization during cardiac muscle cell action potential | 6.70e-05 | 23 | 201 | 4 | GO:0086012 | |
| GeneOntologyBiologicalProcess | regionalization | CYP26A1 GAS8 HOXA10 NEUROD1 HOXD10 CFAP45 PDS5A MED12 HES3 SKI MSGN1 SF3B1 DMRT2 SMARCD3 HES5 | 7.40e-05 | 478 | 201 | 15 | GO:0003002 |
| GeneOntologyBiologicalProcess | chordate embryonic development | MYH9 MRTFB BRCA2 HOXD10 PDS5A PLCG1 GNAS MED12 PRAMEF11 PRAMEF6 WNT7B GINS4 HES3 SKI MSGN1 SLC8A1 SF3B1 DMRT2 SBDS SYVN1 CNOT1 HES5 | 7.82e-05 | 906 | 201 | 22 | GO:0043009 |
| GeneOntologyBiologicalProcess | protein depolymerization | 8.59e-05 | 144 | 201 | 8 | GO:0051261 | |
| GeneOntologyBiologicalProcess | somatic stem cell population maintenance | 9.13e-05 | 108 | 201 | 7 | GO:0035019 | |
| GeneOntologyBiologicalProcess | calcium ion import across plasma membrane | 1.02e-04 | 48 | 201 | 5 | GO:0098703 | |
| GeneOntologyBiologicalProcess | calcium ion import into cytosol | 1.02e-04 | 48 | 201 | 5 | GO:1902656 | |
| GeneOntologyBiologicalProcess | muscle structure development | MYH3 MYH9 MYH11 HLF ACTN2 FBXO22 MRTFB HOXD10 TAFAZZIN COL19A1 WNT7B XBP1 SKI CREB1 SLC8A1 SNW1 PPP3CB SMARCD1 SMARCD2 SMARCD3 MYBPC1 | 1.03e-04 | 858 | 201 | 21 | GO:0061061 |
| GeneOntologyBiologicalProcess | regulation of atrial cardiac muscle cell membrane depolarization | 1.04e-04 | 10 | 201 | 3 | GO:0060371 | |
| GeneOntologyBiologicalProcess | SA node cell to atrial cardiac muscle cell signaling | 1.04e-04 | 10 | 201 | 3 | GO:0086018 | |
| GeneOntologyBiologicalProcess | SA node cell action potential | 1.04e-04 | 10 | 201 | 3 | GO:0086015 | |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | MYH9 MRTFB BRCA2 HOXD10 PDS5A PLCG1 GNAS MED12 PRAMEF11 PRAMEF6 WNT7B GINS4 HES3 SKI MSGN1 SLC8A1 SF3B1 DMRT2 SBDS SYVN1 CNOT1 HES5 | 1.12e-04 | 929 | 201 | 22 | GO:0009792 |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | ZMYND11 RNF168 MBD3L2 BCL7A TLK1 BRCA2 MCM3AP CDYL GNAS TET3 TASP1 NSMCE2 CREB1 DNAJC2 MED15 KAT7 SF3B1 ERCC6L2 SMARCD1 SMARCD2 SMARCD3 TRIM37 L3MBTL4 | 1.18e-04 | 999 | 201 | 23 | GO:0071824 |
| GeneOntologyBiologicalProcess | intracellular transport | SMG1 ABCA1 SYTL2 FYCO1 ACTN2 ALKBH5 SNX13 NUP205 TLK1 FBXO22 NEUROD1 MCM3AP KIF5B KIF5C GNAS WWC1 XBP1 PTPN23 ARCN1 BICDL1 WDR11 NEMF STEEP1 ARHGEF2 SYVN1 CTTN TRIM37 SNX1 SNX5 KIF1C | 1.28e-04 | 1496 | 201 | 30 | GO:0046907 |
| GeneOntologyBiologicalProcess | SA node cell to atrial cardiac muscle cell communication | 1.42e-04 | 11 | 201 | 3 | GO:0086070 | |
| GeneOntologyBiologicalProcess | muscle contraction | MYH2 MYH3 MYH11 ACTN2 GJA5 SCN5A CACNA1G LTB4R TAFAZZIN SLC8A1 SLC8A3 CTTN MYBPC1 | 1.60e-04 | 400 | 201 | 13 | GO:0006936 |
| GeneOntologyBiologicalProcess | chromatin organization | ZMYND11 RNF168 MBD3L2 BCL7A TLK1 BRCA2 MCM3AP CDYL GNAS TET3 TASP1 NSMCE2 DNAJC2 KAT7 SF3B1 ERCC6L2 SMARCD1 SMARCD2 SMARCD3 TRIM37 L3MBTL4 | 1.86e-04 | 896 | 201 | 21 | GO:0006325 |
| GeneOntologyBiologicalProcess | AV node cell to bundle of His cell signaling | 1.88e-04 | 12 | 201 | 3 | GO:0086027 | |
| GeneOntologyBiologicalProcess | AV node cell action potential | 1.88e-04 | 12 | 201 | 3 | GO:0086016 | |
| GeneOntologyBiologicalProcess | pattern specification process | CYP26A1 GAS8 HOXA10 NEUROD1 HOXD10 CFAP45 PDS5A MED12 HES3 SKI MSGN1 SF3B1 DMRT2 SMARCD3 HES5 | 2.11e-04 | 526 | 201 | 15 | GO:0007389 |
| GeneOntologyBiologicalProcess | nucleotide-excision repair | 2.22e-04 | 88 | 201 | 6 | GO:0006289 | |
| GeneOntologyBiologicalProcess | establishment or maintenance of cell polarity | 2.23e-04 | 257 | 201 | 10 | GO:0007163 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | MYH3 MYH9 HOXA10 GJA5 NEUROD1 HOXD10 PDS5A GNAS MED12 WNT7B DUSP5 HES3 SKI USH1C MSGN1 PALS1 MACF1 HES5 | 2.25e-04 | 713 | 201 | 18 | GO:0048598 |
| GeneOntologyBiologicalProcess | regulation of cellular response to stress | RNF168 BCL7A PTEN BRCA2 ETAA1 DIAPH2 TIMELESS XBP1 DNAJC2 OPRM1 KAT7 SMARCD1 SMARCD2 SMARCD3 ARHGEF2 SYVN1 | 2.66e-04 | 598 | 201 | 16 | GO:0080135 |
| GeneOntologyBiologicalProcess | establishment or maintenance of polarity of embryonic epithelium | 2.82e-04 | 3 | 201 | 2 | GO:0016332 | |
| GeneOntologyBiologicalProcess | double-strand break repair | RNF168 BCL7A BRCA2 TIMELESS GINS4 NSMCE2 SMARCD1 SMARCD2 SMARCD3 CDCA5 TOP3A | 3.53e-04 | 324 | 201 | 11 | GO:0006302 |
| GeneOntologyBiologicalProcess | cell cycle process | MYH9 SMC1A RPS6KA2 PAGR1 BCL7A PTEN CABLES1 TLK1 BRCA2 ETAA1 PDS5A TIMELESS CUL1 SMC4 USP37 NSMCE2 USH1C CCDC57 SBDS CEP250 SMARCD1 SMARCD2 SMARCD3 ARHGEF2 CDCA5 STAG2 TRIM37 TOP3A | 3.66e-04 | 1441 | 201 | 28 | GO:0022402 |
| GeneOntologyBiologicalProcess | DNA metabolic process | SMG1 RNF168 SMC1A TRAIP PAGR1 BCL7A BRCA2 ETAA1 ASCC2 PDS5A TIMELESS SMC4 GINS4 USP37 NSMCE2 DNAJC2 KAT7 ERCC6L2 SMARCD1 SMARCD2 SMARCD3 CDCA5 TOP3A | 3.68e-04 | 1081 | 201 | 23 | GO:0006259 |
| GeneOntologyBiologicalProcess | focal adhesion assembly | 3.76e-04 | 97 | 201 | 6 | GO:0048041 | |
| GeneOntologyBiologicalProcess | AV node cell to bundle of His cell communication | 3.80e-04 | 15 | 201 | 3 | GO:0086067 | |
| GeneOntologyBiologicalProcess | cardiac muscle tissue development | MYH11 ACTN2 PTEN GJA5 MRTFB SCN5A CACNA1G TAFAZZIN SKI CREB1 SLC8A1 | 3.82e-04 | 327 | 201 | 11 | GO:0048738 |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 4.04e-04 | 36 | 201 | 4 | GO:0086010 | |
| GeneOntologyBiologicalProcess | cell cycle phase transition | PAGR1 BCL7A PTEN CABLES1 BRCA2 ETAA1 TIMELESS CUL1 USP37 NSMCE2 USH1C CCDC57 SMARCD1 SMARCD2 SMARCD3 CDCA5 | 4.48e-04 | 627 | 201 | 16 | GO:0044770 |
| GeneOntologyBiologicalProcess | heart development | MYH11 RPS6KA2 ACTN2 PTEN GJA5 MRTFB SCN5A PDS5A CACNA1G MED12 TAFAZZIN SKI CREB1 KIF7 SLC8A1 PPP3CB WDR11 SMARCD3 | 4.59e-04 | 757 | 201 | 18 | GO:0007507 |
| GeneOntologyBiologicalProcess | actin filament depolymerization | 4.61e-04 | 66 | 201 | 5 | GO:0030042 | |
| GeneOntologyBiologicalProcess | sister chromatid cohesion | 4.95e-04 | 67 | 201 | 5 | GO:0007062 | |
| GeneOntologyBiologicalProcess | ubiquitin-dependent protein catabolic process via the N-end rule pathway | 5.60e-04 | 4 | 201 | 2 | GO:0071596 | |
| GeneOntologyBiologicalProcess | positive regulation of striated muscle tissue development | 5.60e-04 | 4 | 201 | 2 | GO:0045844 | |
| GeneOntologyBiologicalProcess | Purkinje myocyte action potential | 5.60e-04 | 4 | 201 | 2 | GO:0086017 | |
| GeneOntologyBiologicalProcess | positive regulation of muscle organ development | 5.60e-04 | 4 | 201 | 2 | GO:0048636 | |
| GeneOntologyBiologicalProcess | inner cell mass cell proliferation | 5.61e-04 | 17 | 201 | 3 | GO:0001833 | |
| GeneOntologyBiologicalProcess | regulation of DNA-templated transcription elongation | 5.75e-04 | 105 | 201 | 6 | GO:0032784 | |
| GeneOntologyBiologicalProcess | striated muscle tissue development | MYH11 ACTN2 PTEN GJA5 MRTFB SCN5A CACNA1G TAFAZZIN SKI CREB1 SLC8A1 | 6.57e-04 | 349 | 201 | 11 | GO:0014706 |
| GeneOntologyBiologicalProcess | cell-substrate junction assembly | 6.67e-04 | 108 | 201 | 6 | GO:0007044 | |
| GeneOntologyBiologicalProcess | chromosome segregation | SMC1A BCL7A PTEN TLK1 BRCA2 SMC4 NSMCE2 SMARCD1 SMARCD2 SMARCD3 CDCA5 STAG2 TOP3A | 6.70e-04 | 465 | 201 | 13 | GO:0007059 |
| GeneOntologyBiologicalProcess | mitotic cell cycle process | SMC1A BCL7A PTEN CABLES1 BRCA2 ETAA1 CUL1 SMC4 USP37 NSMCE2 USH1C CCDC57 SBDS SMARCD1 SMARCD2 SMARCD3 ARHGEF2 CDCA5 STAG2 | 7.16e-04 | 854 | 201 | 19 | GO:1903047 |
| GeneOntologyBiologicalProcess | regulation of G0 to G1 transition | 7.33e-04 | 42 | 201 | 4 | GO:0070316 | |
| GeneOntologyBiologicalProcess | organelle assembly | MYH3 SYNPO2 MYH11 SMC1A GAS8 ACTN2 PTEN ALKBH5 DNAH8 DNAH2 PTPN23 CCDC57 WDR11 SBDS CEP250 CFAP58 ARHGEF2 CFAP44 CNOT1 STAG2 TRIM37 RUFY4 MYBPC1 | 7.47e-04 | 1138 | 201 | 23 | GO:0070925 |
| GeneOntologyBiologicalProcess | nuclear chromosome segregation | SMC1A BCL7A PTEN BRCA2 SMC4 NSMCE2 SMARCD1 SMARCD2 SMARCD3 CDCA5 STAG2 | 7.73e-04 | 356 | 201 | 11 | GO:0098813 |
| GeneOntologyBiologicalProcess | membraneless organelle assembly | MYH3 MYH11 SMC1A ACTN2 PTEN ALKBH5 CCDC57 SBDS ARHGEF2 CNOT1 STAG2 TRIM37 MYBPC1 | 8.15e-04 | 475 | 201 | 13 | GO:0140694 |
| GeneOntologyBiologicalProcess | regulation of tube diameter | 8.45e-04 | 202 | 201 | 8 | GO:0035296 | |
| GeneOntologyBiologicalProcess | blood vessel diameter maintenance | 8.45e-04 | 202 | 201 | 8 | GO:0097746 | |
| GeneOntologyBiologicalProcess | regulation of tube size | 8.72e-04 | 203 | 201 | 8 | GO:0035150 | |
| GeneOntologyBiologicalProcess | G0 to G1 transition | 8.76e-04 | 44 | 201 | 4 | GO:0045023 | |
| GeneOntologyBiologicalProcess | regulation of secretion | MYH9 SYTL2 GJA5 NEUROD1 OTOF CACNA1G KIF5B GNAS MICAL1 HTR1A KALRN XBP1 PTPN23 CREB1 OPRM1 PPP3CB STXBP6 MCU | 8.83e-04 | 801 | 201 | 18 | GO:0051046 |
| GeneOntologyBiologicalProcess | sister chromatid segregation | 8.97e-04 | 254 | 201 | 9 | GO:0000819 | |
| GeneOntologyBiologicalProcess | regulation of Wnt protein secretion | 9.27e-04 | 5 | 201 | 2 | GO:0061356 | |
| GeneOntologyBiologicalProcess | membrane depolarization during SA node cell action potential | 9.27e-04 | 5 | 201 | 2 | GO:0086046 | |
| GeneOntologyBiologicalProcess | cell-substrate junction organization | 9.27e-04 | 115 | 201 | 6 | GO:0150115 | |
| GeneOntologyBiologicalProcess | muscle system process | MYH2 MYH3 MYH11 PDE9A ACTN2 GJA5 SCN5A CACNA1G LTB4R TAFAZZIN SLC8A1 SLC8A3 CTTN MYBPC1 | 9.88e-04 | 547 | 201 | 14 | GO:0003012 |
| GeneOntologyBiologicalProcess | sexual reproduction | MYH9 SMC1A RPS6KA2 PANX1 PTEN ALKBH5 HOXA10 BRCA2 HOXD10 DIAPH2 CDYL GNAS TAFAZZIN PRAMEF11 PRAMEF6 CCDC33 ATP8B3 SMC4 MAP7 CREM PPP3CC CFAP58 CFAP44 STAG2 TOP3A | 1.02e-03 | 1312 | 201 | 25 | GO:0019953 |
| GeneOntologyCellularComponent | supramolecular fiber | MYH2 MYH3 SYNPO2 MYH9 MYH11 SPTAN1 GAS8 ACTN2 FBXO22 SCN5A CFAP45 DIAPH2 KIF5B KIF5C DNAH8 MICAL1 KIF21A DNAH2 MAP7 CCDC57 KIF7 SLC8A1 SLC8A3 PPP3CB MACF1 MARK2 ARHGEF2 CTTN MYBPC1 KIF1C | 1.41e-06 | 1179 | 204 | 30 | GO:0099512 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | SRRM1 MYH9 MIS18BP1 DHX38 HLF UPF3B PAGR1 BCL7A NUP205 NEUROD1 BRCA2 MCM3AP AMOTL1 ASCC2 TIMELESS PLCG1 MED12 XBP1 GINS4 PDCD7 INTS8 CREB1 CREM MED15 KAT7 SNW1 SF3B1 INTS4 SMARCD1 SMARCD2 SMARCD3 MPHOSPH6 TRIM37 | 1.48e-06 | 1377 | 204 | 33 | GO:0140513 |
| GeneOntologyCellularComponent | supramolecular polymer | MYH2 MYH3 SYNPO2 MYH9 MYH11 SPTAN1 GAS8 ACTN2 FBXO22 SCN5A CFAP45 DIAPH2 KIF5B KIF5C DNAH8 MICAL1 KIF21A DNAH2 MAP7 CCDC57 KIF7 SLC8A1 SLC8A3 PPP3CB MACF1 MARK2 ARHGEF2 CTTN MYBPC1 KIF1C | 1.62e-06 | 1187 | 204 | 30 | GO:0099081 |
| GeneOntologyCellularComponent | myosin filament | 3.82e-06 | 25 | 204 | 5 | GO:0032982 | |
| GeneOntologyCellularComponent | ruffle | 3.64e-05 | 206 | 204 | 10 | GO:0001726 | |
| GeneOntologyCellularComponent | nuclear periphery | SRRM1 SMC1A NUP205 EBNA1BP2 SNW1 SF3B1 SMARCD1 SMARCD2 STAG2 | 4.79e-05 | 171 | 204 | 9 | GO:0034399 |
| GeneOntologyCellularComponent | kinesin complex | 1.13e-04 | 49 | 204 | 5 | GO:0005871 | |
| GeneOntologyCellularComponent | cell leading edge | MYH9 SLK PDE9A TIAM2 AMOTL1 PLCG1 GNAS WWC1 OPRM1 CSPG4 MACF1 ARHGEF2 CTTN SNX1 SNX5 | 1.24e-04 | 500 | 204 | 15 | GO:0031252 |
| GeneOntologyCellularComponent | contractile muscle fiber | MYH2 MYH3 SYNPO2 MYH11 SPTAN1 ACTN2 FBXO22 SCN5A SLC8A1 PPP3CB MYBPC1 | 1.38e-04 | 290 | 204 | 11 | GO:0043292 |
| GeneOntologyCellularComponent | myosin II complex | 1.50e-04 | 28 | 204 | 4 | GO:0016460 | |
| GeneOntologyCellularComponent | sarcomere | MYH2 MYH3 SYNPO2 SPTAN1 ACTN2 FBXO22 SCN5A SLC8A1 PPP3CB MYBPC1 | 1.75e-04 | 249 | 204 | 10 | GO:0030017 |
| GeneOntologyCellularComponent | microtubule associated complex | 1.88e-04 | 161 | 204 | 8 | GO:0005875 | |
| GeneOntologyCellularComponent | SWI/SNF complex | 1.98e-04 | 30 | 204 | 4 | GO:0016514 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | MYH9 GAS8 ACTN2 CFAP45 DIAPH2 KIF5B KIF5C DNAH8 MICAL1 KIF21A DNAH2 MAP7 CCDC57 KIF7 SLC8A1 SLC8A3 MACF1 MARK2 ARHGEF2 CTTN KIF1C | 2.00e-04 | 899 | 204 | 21 | GO:0099513 |
| GeneOntologyCellularComponent | microtubule | GAS8 CFAP45 KIF5B KIF5C DNAH8 KIF21A DNAH2 MAP7 CCDC57 KIF7 SLC8A1 SLC8A3 MACF1 ARHGEF2 KIF1C | 2.48e-04 | 533 | 204 | 15 | GO:0005874 |
| GeneOntologyCellularComponent | brahma complex | 3.08e-04 | 14 | 204 | 3 | GO:0035060 | |
| GeneOntologyCellularComponent | myofibril | MYH2 MYH3 SYNPO2 SPTAN1 ACTN2 FBXO22 SCN5A SLC8A1 PPP3CB MYBPC1 | 3.66e-04 | 273 | 204 | 10 | GO:0030016 |
| GeneOntologyCellularComponent | nuclear matrix | 4.57e-04 | 140 | 204 | 7 | GO:0016363 | |
| GeneOntologyCellularComponent | muscle myosin complex | 4.67e-04 | 16 | 204 | 3 | GO:0005859 | |
| GeneOntologyCellularComponent | actin cytoskeleton | MYH2 MYH3 SYNPO2 MYH9 MYH11 SPTAN1 ACTN2 DIAPH2 MICAL1 KALRN SH3GL1 MACF1 MARK2 ARHGEF2 CTTN | 5.58e-04 | 576 | 204 | 15 | GO:0015629 |
| GeneOntologyCellularComponent | ATF4-CREB1 transcription factor complex | 5.61e-04 | 4 | 204 | 2 | GO:1990589 | |
| GeneOntologyCellularComponent | retromer, tubulation complex | 5.61e-04 | 4 | 204 | 2 | GO:0030905 | |
| GeneOntologyCellularComponent | sarcolemma | 5.72e-04 | 190 | 204 | 8 | GO:0042383 | |
| GeneOntologyCellularComponent | anchoring junction | MYH2 SYNPO2 MYH9 SPTAN1 PANX1 ACTN2 GJA5 AMOTL1 SCN5A KAZN PLCG1 PLEKHA7 SH3GL1 OPRM1 PALS1 SLC8A1 SLC8A3 STXBP6 CSPG4 ARHGEF2 CTTN | 5.93e-04 | 976 | 204 | 21 | GO:0070161 |
| GeneOntologyCellularComponent | Z disc | 7.18e-04 | 151 | 204 | 7 | GO:0030018 | |
| GeneOntologyCellularComponent | somatodendritic compartment | PDE9A UPF3B ACTN2 PTEN GPR179 TIAM2 CACNA1G KIF5B KIF5C GNAS HTR1A KALRN KIF21A GRIA4 CNKSR2 OPRM1 PALS1 SLC8A1 SLC8A3 MARK2 ARHGEF2 CTTN SNX1 KIF1C | 9.35e-04 | 1228 | 204 | 24 | GO:0036477 |
| GeneOntologyCellularComponent | I band | 1.25e-03 | 166 | 204 | 7 | GO:0031674 | |
| GeneOntologyCellularComponent | postsynaptic density, intracellular component | 1.32e-03 | 49 | 204 | 4 | GO:0099092 | |
| GeneOntologyCellularComponent | calcineurin complex | 1.39e-03 | 6 | 204 | 2 | GO:0005955 | |
| GeneOntologyCellularComponent | DNA repair complex | 1.40e-03 | 23 | 204 | 3 | GO:1990391 | |
| GeneOntologyCellularComponent | chromosome, centromeric region | 1.61e-03 | 276 | 204 | 9 | GO:0000775 | |
| GeneOntologyCellularComponent | ATPase complex | 1.69e-03 | 129 | 204 | 6 | GO:1904949 | |
| GeneOntologyCellularComponent | mitotic cohesin complex | 1.93e-03 | 7 | 204 | 2 | GO:0030892 | |
| GeneOntologyCellularComponent | myelin sheath adaxonal region | 1.93e-03 | 7 | 204 | 2 | GO:0035749 | |
| GeneOntologyCellularComponent | actomyosin contractile ring | 1.93e-03 | 7 | 204 | 2 | GO:0005826 | |
| GeneOntologyCellularComponent | dendrite | ACTN2 PTEN GPR179 CACNA1G KIF5B KIF5C GNAS HTR1A KIF21A GRIA4 OPRM1 SLC8A1 SLC8A3 MARK2 ARHGEF2 CTTN SNX1 KIF1C | 1.93e-03 | 858 | 204 | 18 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | ACTN2 PTEN GPR179 CACNA1G KIF5B KIF5C GNAS HTR1A KIF21A GRIA4 OPRM1 SLC8A1 SLC8A3 MARK2 ARHGEF2 CTTN SNX1 KIF1C | 1.98e-03 | 860 | 204 | 18 | GO:0097447 |
| GeneOntologyCellularComponent | cell-cell junction | MYH2 MYH9 SPTAN1 PANX1 GJA5 AMOTL1 SCN5A KAZN PLCG1 PLEKHA7 PALS1 SLC8A1 STXBP6 ARHGEF2 | 2.07e-03 | 591 | 204 | 14 | GO:0005911 |
| GeneOntologyCellularComponent | postsynaptic specialization, intracellular component | 2.18e-03 | 56 | 204 | 4 | GO:0099091 | |
| GeneOntologyCellularComponent | cortical actin cytoskeleton | 2.19e-03 | 93 | 204 | 5 | GO:0030864 | |
| GeneOntologyCellularComponent | postsynapse | TRIO SPTAN1 ACTN2 PTEN GPR179 KIF5B KIF5C RPL36 KALRN SH3GL1 GRIA4 CNKSR2 OPRM1 SLC8A1 SLC8A3 MACF1 MARK2 ARHGEF2 CTTN SNX1 | 2.36e-03 | 1018 | 204 | 20 | GO:0098794 |
| GeneOntologyCellularComponent | spindle | MYH9 SMC1A RPS6KA1 RPS6KA2 MICAL3 MAP7D3 CCDC57 SBDS CEP250 ARHGEF2 CTTN STAG2 | 2.37e-03 | 471 | 204 | 12 | GO:0005819 |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 2.51e-03 | 96 | 204 | 5 | GO:0070603 | |
| GeneOntologyCellularComponent | myosin complex | 2.64e-03 | 59 | 204 | 4 | GO:0016459 | |
| GeneOntologyCellularComponent | dendritic spine | 2.67e-03 | 242 | 204 | 8 | GO:0043197 | |
| GeneOntologyCellularComponent | sodium channel complex | 2.78e-03 | 29 | 204 | 3 | GO:0034706 | |
| GeneOntologyCellularComponent | cytoplasmic region | 2.93e-03 | 360 | 204 | 10 | GO:0099568 | |
| GeneOntologyCellularComponent | chromosomal region | MIS18BP1 SMC1A BRCA2 PDS5A SMC4 NSMCE2 KAT7 SMARCD1 SMARCD2 CDCA5 STAG2 | 2.94e-03 | 421 | 204 | 11 | GO:0098687 |
| GeneOntologyCellularComponent | neuron spine | 3.02e-03 | 247 | 204 | 8 | GO:0044309 | |
| GeneOntologyCellularComponent | actin filament | 3.14e-03 | 146 | 204 | 6 | GO:0005884 | |
| GeneOntologyCellularComponent | cilium | GAS8 ADCY6 CFAP45 KIF5B KIF5C DNAH8 PRAMEF11 PRAMEF6 IQCE DNAH2 PTPN23 USH1C KIF7 PPP3CC WDR11 CEP250 CFAP58 CFAP44 | 3.15e-03 | 898 | 204 | 18 | GO:0005929 |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 4.07e-03 | 317 | 204 | 9 | GO:0032838 | |
| GeneOntologyCellularComponent | ruffle membrane | 4.17e-03 | 108 | 204 | 5 | GO:0032587 | |
| GeneOntologyCellularComponent | intercalated disc | 4.41e-03 | 68 | 204 | 4 | GO:0014704 | |
| GeneOntologyCellularComponent | leading edge membrane | 4.65e-03 | 210 | 204 | 7 | GO:0031256 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | ABCA1 SLK ATP6V0A1 PDE9A TRAIP SCN5A CACNA1G KIF5B GNAS WWC1 EPN3 KALRN MAP7 SLC8A3 CEP250 TRIM37 SNX1 SNX5 | 4.73e-03 | 934 | 204 | 18 | GO:0048471 |
| GeneOntologyCellularComponent | cytosolic region | 4.89e-03 | 70 | 204 | 4 | GO:0099522 | |
| GeneOntologyCellularComponent | cohesin complex | 4.92e-03 | 11 | 204 | 2 | GO:0008278 | |
| GeneOntologyCellularComponent | postsynaptic density | ACTN2 PTEN KALRN SH3GL1 GRIA4 CNKSR2 SLC8A1 SLC8A3 MACF1 ARHGEF2 SNX1 | 4.92e-03 | 451 | 204 | 11 | GO:0014069 |
| MousePheno | abnormal embryonic tissue physiology | SMG1 SLK TRAIP GCLC CFAP45 EBNA1BP2 MED12 GINS4 MSGN1 KAT7 EEF2 SLC8A1 SBDS TOP3A | 1.96e-05 | 297 | 173 | 14 | MP:0008932 |
| MousePheno | abnormal muscle morphology | UBR1 MYH3 ZMYND11 ABCA1 SLK MYH11 TRIO RPS6KA2 SPTAN1 RPS6KA3 ACTN2 PTEN MRTFB SCN5A COL19A1 KALRN KIF21A XBP1 SKI CREB1 KIF7 MSGN1 SLC8A1 SLC8A3 PPP3CB DMRT2 NEMF SMARCD3 TRIM37 MYBPC1 | 3.50e-05 | 1106 | 173 | 30 | MP:0002108 |
| MousePheno | abnormal myogenesis | 4.18e-05 | 52 | 173 | 6 | MP:0000729 | |
| MousePheno | abnormal prenatal growth/weight/body size | SMG1 ABCA1 MYH9 SLK TRIO TRAIP SPTAN1 PAGR1 MCCC1 BCL7A PTEN SNX13 RGL1 ATAD3C BRCA2 GCLC SCN5A PDS5A KIF5B PLCG1 CUL1 UBR4 TASP1 XBP1 PTPN23 SKI NSMCE2 CREB1 MSGN1 KAT7 EEF2 SLC8A1 WDR11 SBDS STEEP1 MARK2 | 6.33e-05 | 1493 | 173 | 36 | MP:0004196 |
| Domain | Ribosomal_S6_kinase_II | 1.88e-07 | 6 | 200 | 4 | IPR016239 | |
| Domain | SWIB_domain | 1.21e-06 | 3 | 200 | 3 | IPR019835 | |
| Domain | SWIB | 1.21e-06 | 3 | 200 | 3 | SM00151 | |
| Domain | Spectrin | 3.85e-06 | 23 | 200 | 5 | PF00435 | |
| Domain | SWIB | 1.19e-05 | 5 | 200 | 3 | PF02201 | |
| Domain | Spectrin_repeat | 1.29e-05 | 29 | 200 | 5 | IPR002017 | |
| Domain | Myosin_N | 1.59e-05 | 15 | 200 | 4 | PF02736 | |
| Domain | Myosin_N | 1.59e-05 | 15 | 200 | 4 | IPR004009 | |
| Domain | SPEC | 2.13e-05 | 32 | 200 | 5 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 2.13e-05 | 32 | 200 | 5 | IPR018159 | |
| Domain | - | 2.36e-05 | 6 | 200 | 3 | 1.10.245.10 | |
| Domain | SWIB_MDM2_domain | 2.36e-05 | 6 | 200 | 3 | IPR003121 | |
| Domain | Myosin_tail_1 | 3.47e-05 | 18 | 200 | 4 | PF01576 | |
| Domain | Myosin_tail | 3.47e-05 | 18 | 200 | 4 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 4.36e-05 | 19 | 200 | 4 | IPR027401 | |
| Domain | - | 4.36e-05 | 19 | 200 | 4 | 4.10.270.10 | |
| Domain | Kinesin_motor_CS | 7.34e-05 | 41 | 200 | 5 | IPR019821 | |
| Domain | Kinesin-like_fam | 9.26e-05 | 43 | 200 | 5 | IPR027640 | |
| Domain | - | 1.04e-04 | 44 | 200 | 5 | 3.40.850.10 | |
| Domain | Kinesin | 1.04e-04 | 44 | 200 | 5 | PF00225 | |
| Domain | KISc | 1.04e-04 | 44 | 200 | 5 | SM00129 | |
| Domain | KINESIN_MOTOR_1 | 1.04e-04 | 44 | 200 | 5 | PS00411 | |
| Domain | Kinesin_motor_dom | 1.04e-04 | 44 | 200 | 5 | IPR001752 | |
| Domain | KINESIN_MOTOR_2 | 1.04e-04 | 44 | 200 | 5 | PS50067 | |
| Domain | IQ | 2.33e-04 | 81 | 200 | 6 | SM00015 | |
| Domain | P-loop_NTPase | MYH2 MYH3 ABCA1 MYH9 MYH11 SMC1A DHX38 PSMC1 ATAD3C KIF5B KIF5C GNAS DNAH8 KIF21A DNAH2 SMC4 KIF7 PALS1 EEF2 ERCC6L2 KIF1C | 3.13e-04 | 848 | 200 | 21 | IPR027417 |
| Domain | PWI | 3.40e-04 | 3 | 200 | 2 | SM00311 | |
| Domain | PWI | 3.40e-04 | 3 | 200 | 2 | PS51025 | |
| Domain | pKID | 3.40e-04 | 3 | 200 | 2 | PF02173 | |
| Domain | KID | 3.40e-04 | 3 | 200 | 2 | PS50953 | |
| Domain | Na_Ca_Ex | 3.40e-04 | 3 | 200 | 2 | IPR004836 | |
| Domain | Na_Ca_Ex_C-exten | 3.40e-04 | 3 | 200 | 2 | IPR032452 | |
| Domain | Na_Ca_ex_C | 3.40e-04 | 3 | 200 | 2 | PF16494 | |
| Domain | Coactivator_CBP_pKID | 3.40e-04 | 3 | 200 | 2 | IPR003102 | |
| Domain | IQ_motif_EF-hand-BS | 4.13e-04 | 90 | 200 | 6 | IPR000048 | |
| Domain | IQ | 4.92e-04 | 93 | 200 | 6 | PS50096 | |
| Domain | Pkinase_C | 6.39e-04 | 37 | 200 | 4 | IPR017892 | |
| Domain | Leuzip_CREB | 6.75e-04 | 4 | 200 | 2 | IPR001630 | |
| Domain | MAP7 | 6.75e-04 | 4 | 200 | 2 | PF05672 | |
| Domain | MAP7_fam | 6.75e-04 | 4 | 200 | 2 | IPR008604 | |
| Domain | Myosin_head_motor_dom | 7.08e-04 | 38 | 200 | 4 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 7.08e-04 | 38 | 200 | 4 | PS51456 | |
| Domain | Myosin_head | 7.08e-04 | 38 | 200 | 4 | PF00063 | |
| Domain | MYSc | 7.08e-04 | 38 | 200 | 4 | SM00242 | |
| Domain | IQ | 9.84e-04 | 71 | 200 | 5 | PF00612 | |
| Domain | Pkinase_C | 1.04e-03 | 42 | 200 | 4 | PF00433 | |
| Domain | PDZ | 1.09e-03 | 148 | 200 | 7 | SM00228 | |
| Domain | SMC | 1.12e-03 | 5 | 200 | 2 | IPR024704 | |
| Domain | PWI | 1.12e-03 | 5 | 200 | 2 | PF01480 | |
| Domain | Vps5_C | 1.12e-03 | 5 | 200 | 2 | IPR015404 | |
| Domain | Vps5 | 1.12e-03 | 5 | 200 | 2 | PF09325 | |
| Domain | - | 1.12e-03 | 5 | 200 | 2 | 1.20.1390.10 | |
| Domain | PWI_dom | 1.12e-03 | 5 | 200 | 2 | IPR002483 | |
| Domain | - | 1.18e-03 | 150 | 200 | 7 | 2.30.42.10 | |
| Domain | PDZ | 1.22e-03 | 151 | 200 | 7 | PS50106 | |
| Domain | PDZ | 1.27e-03 | 152 | 200 | 7 | IPR001478 | |
| Domain | Znf_C2HC | 1.66e-03 | 6 | 200 | 2 | IPR002515 | |
| Domain | SMC_hinge | 1.66e-03 | 6 | 200 | 2 | SM00968 | |
| Domain | FAD-bd | 1.66e-03 | 6 | 200 | 2 | IPR002938 | |
| Domain | zf-C2HC | 1.66e-03 | 6 | 200 | 2 | PF01530 | |
| Domain | FAD_binding_3 | 1.66e-03 | 6 | 200 | 2 | PF01494 | |
| Domain | EFhand_Ca_insen | 1.66e-03 | 6 | 200 | 2 | PF08726 | |
| Domain | SMC_hinge | 1.66e-03 | 6 | 200 | 2 | PF06470 | |
| Domain | EF-hand_Ca_insen | 1.66e-03 | 6 | 200 | 2 | IPR014837 | |
| Domain | SMC_hinge | 1.66e-03 | 6 | 200 | 2 | IPR010935 | |
| Domain | BRLZ | 2.31e-03 | 52 | 200 | 4 | SM00338 | |
| Domain | DUF3585 | 2.31e-03 | 7 | 200 | 2 | IPR022735 | |
| Domain | DUF3585 | 2.31e-03 | 7 | 200 | 2 | PF12130 | |
| Domain | ZnF_UBR1 | 2.31e-03 | 7 | 200 | 2 | SM00396 | |
| Domain | ZF_CCHHC | 2.31e-03 | 7 | 200 | 2 | PS51802 | |
| Domain | ZF_UBR | 2.31e-03 | 7 | 200 | 2 | PS51157 | |
| Domain | zf-UBR | 2.31e-03 | 7 | 200 | 2 | PF02207 | |
| Domain | Znf_UBR | 2.31e-03 | 7 | 200 | 2 | IPR003126 | |
| Domain | SH3 | 2.33e-03 | 216 | 200 | 8 | PS50002 | |
| Domain | BZIP_BASIC | 2.48e-03 | 53 | 200 | 4 | PS00036 | |
| Domain | BZIP | 2.48e-03 | 53 | 200 | 4 | PS50217 | |
| Domain | SH3_domain | 2.61e-03 | 220 | 200 | 8 | IPR001452 | |
| Domain | bZIP | 2.66e-03 | 54 | 200 | 4 | IPR004827 | |
| Domain | AGC-kinase_C | 3.03e-03 | 56 | 200 | 4 | IPR000961 | |
| Domain | AGC_KINASE_CTER | 3.03e-03 | 56 | 200 | 4 | PS51285 | |
| Domain | S_TK_X | 3.03e-03 | 56 | 200 | 4 | SM00133 | |
| Domain | DHC_N1 | 3.06e-03 | 8 | 200 | 2 | PF08385 | |
| Domain | Calx_beta | 3.06e-03 | 8 | 200 | 2 | SM00237 | |
| Domain | RecF/RecN/SMC_N | 3.06e-03 | 8 | 200 | 2 | IPR003395 | |
| Domain | SMC_N | 3.06e-03 | 8 | 200 | 2 | PF02463 | |
| Domain | Dynein_heavy_dom-1 | 3.06e-03 | 8 | 200 | 2 | IPR013594 | |
| Domain | PTPc_motif | 3.67e-03 | 59 | 200 | 4 | SM00404 | |
| Domain | Tyr_Pase_cat | 3.67e-03 | 59 | 200 | 4 | IPR003595 | |
| Domain | Calx_beta | 3.91e-03 | 9 | 200 | 2 | IPR003644 | |
| Domain | NaCa_Exmemb | 3.91e-03 | 9 | 200 | 2 | IPR004837 | |
| Domain | Na_Ca_ex | 3.91e-03 | 9 | 200 | 2 | PF01699 | |
| Domain | Calx-beta | 3.91e-03 | 9 | 200 | 2 | PF03160 | |
| Domain | PDZ | 4.15e-03 | 141 | 200 | 6 | PF00595 | |
| Domain | DH_1 | 4.64e-03 | 63 | 200 | 4 | PS00741 | |
| Domain | CH | 5.19e-03 | 65 | 200 | 4 | SM00033 | |
| Domain | Ser/Thr_kinase_AS | SLK TRIO RPS6KA1 RPS6KA2 RPS6KA3 TLK1 RPS6KA6 KALRN MARK2 MAPK4 | 5.26e-03 | 357 | 200 | 10 | IPR008271 |
| Domain | S_TKc | SLK TRIO RPS6KA1 RPS6KA2 RPS6KA3 TLK1 RPS6KA6 KALRN MARK2 MAPK4 | 5.46e-03 | 359 | 200 | 10 | SM00220 |
| Domain | PROTEIN_KINASE_ST | SLK TRIO RPS6KA1 RPS6KA2 RPS6KA3 TLK1 RPS6KA6 KALRN MARK2 MAPK4 | 5.78e-03 | 362 | 200 | 10 | PS00108 |
| Domain | RhoGEF | 6.09e-03 | 68 | 200 | 4 | SM00325 | |
| Domain | RhoGEF | 6.75e-03 | 70 | 200 | 4 | PF00621 | |
| Pathway | REACTOME_CREB1_PHOSPHORYLATION_THROUGH_NMDA_RECEPTOR_MEDIATED_ACTIVATION_OF_RAS_SIGNALING | 2.33e-10 | 5 | 169 | 5 | MM15108 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 1.59e-07 | 35 | 169 | 7 | MM15109 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ERK_RSK_SIGNALING | 2.94e-07 | 6 | 169 | 4 | M47936 | |
| Pathway | REACTOME_POST_NMDA_RECEPTOR_ACTIVATION_EVENTS | 6.36e-07 | 15 | 169 | 5 | MM15103 | |
| Pathway | WP_THERMOGENESIS | RPS6KA1 RPS6KA2 RPS6KA3 ADCY6 RPS6KA6 GNAS CREB1 SMARCD1 SMARCD2 SMARCD3 | 6.62e-07 | 108 | 169 | 10 | M39746 |
| Pathway | REACTOME_CREB_PHOSPHORYLATION | 6.78e-07 | 7 | 169 | 4 | M27096 | |
| Pathway | REACTOME_CREB_PHOSPHORYLATION | 6.78e-07 | 7 | 169 | 4 | MM14784 | |
| Pathway | REACTOME_RSK_ACTIVATION | 6.78e-07 | 7 | 169 | 4 | M27369 | |
| Pathway | REACTOME_CREB1_PHOSPHORYLATION_THROUGH_NMDA_RECEPTOR_MEDIATED_ACTIVATION_OF_RAS_SIGNALING | 8.22e-07 | 28 | 169 | 6 | M837 | |
| Pathway | KEGG_OOCYTE_MEIOSIS | SLK SMC1A RPS6KA1 RPS6KA2 RPS6KA3 ADCY6 RPS6KA6 CUL1 PPP3CB PPP3CC | 1.01e-06 | 113 | 169 | 10 | M16817 |
| Pathway | KEGG_TIGHT_JUNCTION | 4.17e-06 | 132 | 169 | 10 | M11355 | |
| Pathway | REACTOME_ESTABLISHMENT_OF_SISTER_CHROMATID_COHESION | 6.16e-06 | 11 | 169 | 4 | M27177 | |
| Pathway | REACTOME_ESTABLISHMENT_OF_SISTER_CHROMATID_COHESION | 6.16e-06 | 11 | 169 | 4 | MM14891 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION | 9.97e-06 | 42 | 169 | 6 | M48237 | |
| Pathway | BIOCARTA_GPCR_PATHWAY | 2.20e-05 | 29 | 169 | 5 | MM1495 | |
| Pathway | BIOCARTA_GPCR_PATHWAY | 2.61e-05 | 30 | 169 | 5 | M9664 | |
| Pathway | REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK | 3.24e-05 | 16 | 169 | 4 | MM15477 | |
| Pathway | REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK | 5.35e-05 | 18 | 169 | 4 | M657 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY | 5.66e-05 | 35 | 169 | 5 | M47969 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ESTABLISHMENT_OF_COHESION | 5.72e-05 | 7 | 169 | 3 | M47869 | |
| Pathway | REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS | 1.34e-04 | 94 | 169 | 7 | M2843 | |
| Pathway | REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION | 1.43e-04 | 95 | 169 | 7 | M48268 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | MYH9 MYH11 ATP6V0A1 TRIO RPS6KA1 RPS6KA2 SPTAN1 RPS6KA3 SYTL2 PSMC1 UPF3B PAGR1 BCL7A NEUROD1 SCN5A RPS6KA6 CACNA1G KAZN PLCG1 TET3 MED12 RPL36 KALRN CREB1 MSGN1 MED15 SNW1 PPP3CB CSPG4 SMARCD1 SMARCD2 SMARCD3 CNOT1 | 1.72e-04 | 1432 | 169 | 33 | M509 |
| Pathway | KEGG_LONG_TERM_POTENTIATION | 1.89e-04 | 70 | 169 | 6 | M3115 | |
| Pathway | REACTOME_COHESIN_LOADING_ONTO_CHROMATIN | 1.91e-04 | 10 | 169 | 3 | M27178 | |
| Pathway | REACTOME_COHESIN_LOADING_ONTO_CHROMATIN | 1.91e-04 | 10 | 169 | 3 | MM14892 | |
| Pathway | REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT | 2.44e-04 | 137 | 169 | 8 | M48232 | |
| Pathway | REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION | 2.82e-04 | 27 | 169 | 4 | MM14779 | |
| Pathway | REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES | 3.26e-04 | 28 | 169 | 4 | MM15132 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 3.42e-04 | 144 | 169 | 8 | MM14501 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 3.75e-04 | 29 | 169 | 4 | M48076 | |
| Pathway | REACTOME_S_PHASE | 3.75e-04 | 146 | 169 | 8 | MM15378 | |
| Pathway | REACTOME_MITOTIC_TELOPHASE_CYTOKINESIS | 4.43e-04 | 13 | 169 | 3 | MM15363 | |
| Pathway | REACTOME_MITOTIC_TELOPHASE_CYTOKINESIS | 4.43e-04 | 13 | 169 | 3 | M27661 | |
| Pathway | REACTOME_SIGNALING_BY_HEDGEHOG | 4.49e-04 | 150 | 169 | 8 | M27440 | |
| Pathway | REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES | 4.87e-04 | 31 | 169 | 4 | M15195 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | MYH9 MYH11 TRIO RPS6KA1 RPS6KA2 SPTAN1 RPS6KA3 PSMC1 UPF3B SCN5A RPS6KA6 CACNA1G PLCG1 RPL36 KALRN CREB1 PPP3CB | 5.48e-04 | 575 | 169 | 17 | M29853 |
| Pathway | BIOCARTA_ERK5_PATHWAY | 5.59e-04 | 14 | 169 | 3 | MM1481 | |
| Pathway | BIOCARTA_ERK5_PATHWAY | 5.59e-04 | 14 | 169 | 3 | M16811 | |
| Pathway | WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS | 6.54e-04 | 88 | 169 | 6 | M39495 | |
| Pathway | WP_INSULIN_SIGNALING | 6.89e-04 | 160 | 169 | 8 | MM15956 | |
| Pathway | WP_INSULIN_SIGNALING | 6.89e-04 | 160 | 169 | 8 | M39482 | |
| Pathway | REACTOME_INTERLEUKIN_17_SIGNALING | 6.93e-04 | 59 | 169 | 5 | MM15128 | |
| Pathway | WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME | 6.98e-04 | 34 | 169 | 4 | M42555 | |
| Pathway | REACTOME_S_PHASE | 7.78e-04 | 163 | 169 | 8 | M3158 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CALCINEURIN_SIGNALING_PATHWAY | 8.45e-04 | 16 | 169 | 3 | M47449 | |
| Pathway | SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES | 8.71e-04 | 36 | 169 | 4 | M1315 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAQ_PLCB_G_CALCINEURIN | 1.02e-03 | 17 | 169 | 3 | M47560 | |
| Pathway | REACTOME_MRNA_SPLICING | 1.04e-03 | 212 | 169 | 9 | M14033 | |
| Pathway | PID_RAC1_REG_PATHWAY | 1.07e-03 | 38 | 169 | 4 | M241 | |
| Pathway | WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION | 1.07e-03 | 38 | 169 | 4 | M39854 | |
| Pathway | BIOCARTA_CALCINEURIN_PATHWAY | 1.21e-03 | 18 | 169 | 3 | MM1385 | |
| Pathway | BIOCARTA_CALCINEURIN_PATHWAY | 1.21e-03 | 18 | 169 | 3 | M3430 | |
| Pathway | SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES | 1.24e-03 | 67 | 169 | 5 | M295 | |
| Pubmed | SMG1 SRRM1 MYH2 MYH3 MYH9 MYH11 SPTAN1 ACTN2 ADCY6 NUP205 TLK1 UBXN4 ATAD3C GCLC CFAP45 KIF5B KIF5C EBNA1BP2 DNAH8 RPL36 KIF21A UBR4 DNAH2 SMC4 GRIA4 SKI CCDC57 EEF2 SF3B1 CSPG4 MACF1 SMARCD2 ARHGEF2 CTTN STAG2 CCDC158 MYBPC1 | 4.91e-14 | 1442 | 206 | 37 | 35575683 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | MIS18BP1 TRIO PSMC1 MCCC1 NUP205 MRTFB BRCA2 MICAL3 KIF5B KIF5C NKAP PLEKHA7 MAP7D3 SH3GL1 PTPN23 CCDC57 ARCN1 KIF7 IARS2 WDR11 CEP250 MCU ARHGEF2 CTTN CNOT1 TRIM37 KIF1C | 1.61e-12 | 853 | 206 | 27 | 28718761 |
| Pubmed | Cognitive impairment in Coffin-Lowry syndrome correlates with reduced RSK2 activation. | 6.94e-12 | 5 | 206 | 5 | 11160957 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | SRRM1 MYH9 SMC1A SPTAN1 PSMC1 SFI1 EBNA1BP2 GNAS CUL1 KIF21A SMC4 MAP7 INTS8 ARCN1 SNW1 SF3B1 MACF1 MARK2 ARHGEF2 CTTN CNOT1 STAG2 | 7.19e-12 | 582 | 206 | 22 | 20467437 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | SRRM1 MYH9 SLK SMC1A SPTAN1 DHX38 PSMC1 UPF3B FBXO22 SLC7A6OS PDS5A KIF5B EBNA1BP2 RPL36 KIF21A SH3GL1 UBR4 SMC4 PTPN23 MAP7 ARCN1 DNAJC2 EEF2 SNW1 SF3B1 NEMF MACF1 ARHGEF2 CTTN STAG2 SNX1 KIF1C | 8.03e-11 | 1415 | 206 | 32 | 28515276 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | MYH9 SMC1A SPTAN1 DHX38 PSMC1 NDUFB10 NUP205 RBM25 AMOTL1 ASCC2 KIF5B EBNA1BP2 GNAS RPL36 MAP7D3 SMC4 MAP7 ARCN1 DNAJC2 PALS1 EEF2 IARS2 SNW1 SF3B1 PPP3CB WDR11 SMARCD2 MARK2 ARHGEF2 CTTN | 9.30e-11 | 1257 | 206 | 30 | 36526897 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | MYH9 SLK ATP6V0A1 TRIO SMC1A SPTAN1 DHX38 PSMC1 UPF3B NUP205 RBM25 GCLC PDS5A KIF5B PLCG1 EBNA1BP2 GNAS PLEKHA7 CUL1 RPL36 UBR4 SMC4 ARCN1 EEF2 IARS2 SNW1 SF3B1 NEMF CTTN CNOT1 STAG2 MYBPC1 | 9.59e-11 | 1425 | 206 | 32 | 30948266 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | PALD1 TRIO RPS6KA2 PANX1 FYCO1 SFI1 BCL7A TIAM2 CABLES1 TLK1 MCM3AP SCN5A DIAPH2 MICAL3 PLCG1 MED12 IQCE EPN3 KALRN WNT7B DUSP5 UBR4 TASP1 KLHL25 CSPG4 ARHGEF2 SYVN1 TOP3A | 1.09e-10 | 1105 | 206 | 28 | 35748872 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | UBR1 MYH9 MIS18BP1 SMC1A SPTAN1 DHX38 PSMC1 MCCC1 NUP205 FBXO22 MCM3AP PDS5A KIF5B PLCG1 EBNA1BP2 MED12 CUL1 RPL36 KIF21A UBR4 SMC4 PTPN23 ARCN1 KAT7 EEF2 SNW1 SF3B1 WDR11 SBDS MACF1 ARHGEF2 | 1.19e-10 | 1353 | 206 | 31 | 29467282 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SRRM1 MYH9 RNF168 SMC1A DHX38 PAGR1 MCCC1 NDUFB10 HOXA10 RBM25 PDS5A CDYL EBNA1BP2 TET3 CUL1 RPL36 MAP7D3 MAP7 SKI CREB1 CREM CLASRP KAT7 SNW1 SF3B1 STEEP1 INTS4 CDCA5 STAG2 TOP3A | 1.86e-10 | 1294 | 206 | 30 | 30804502 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | MYH9 SLK MYH11 SMC1A SPTAN1 PSMC1 UPF3B RBM25 UBXN4 KIF5B KIF5C CUL1 RPL36 KIF21A DNAH2 SMC4 ARCN1 SF3B1 SBDS CEP250 MACF1 SMARCD2 SMARCD3 CTTN | 2.87e-10 | 847 | 206 | 24 | 35235311 |
| Pubmed | SRRM1 ZMYND11 MYH9 MIS18BP1 RNF168 SMC1A DHX38 NUP205 RBM25 PDS5A MED12 CUL1 UBR4 SMC4 GINS4 MED15 KAT7 EEF2 SNW1 SF3B1 SBDS STEEP1 SMARCD1 SMARCD2 CTTN STAG2 | 4.16e-10 | 1014 | 206 | 26 | 32416067 | |
| Pubmed | PALD1 SMG1 SRRM1 MYH2 SPTAN1 RPS6KA3 PSMC1 MCCC1 NDUFB10 NUP205 ASCC2 PDS5A MICAL3 EBNA1BP2 GNAS CUL1 RPL36 SH3GL1 UBR4 SMC4 MAP7 IFIT1 ARCN1 KAT7 EEF2 IARS2 SF3B1 ARHGEF2 CTTN CNOT1 STAG2 | 5.43e-10 | 1440 | 206 | 31 | 30833792 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | MYH9 SLK SMC1A RPS6KA1 SPTAN1 RPS6KA3 DHX38 PSMC1 NUP205 GCLC TIMELESS KIF5B PLCG1 CUL1 RPL36 KIF21A SH3GL1 UBR4 SMC4 GINS4 PTPN23 MAP7 ARCN1 EEF2 PPP3CB SBDS MACF1 CTTN CNOT1 SNX1 SNX5 | 6.96e-10 | 1455 | 206 | 31 | 22863883 |
| Pubmed | MYH9 SLK TRIO RPS6KA2 SPTAN1 FYCO1 ITIH1 DIAPH2 KIF5B KIF5C KALRN KIF21A UBR4 GRIA4 CNKSR2 KIF7 PALS1 EEF2 SNW1 SF3B1 PPP3CB MACF1 ARHGEF2 CTTN CNOT1 | 7.21e-10 | 963 | 206 | 25 | 28671696 | |
| Pubmed | SLK SPTAN1 RBM25 MRTFB AMOTL1 KIF5B MED12 MAP7D3 SH3GL1 SMC4 PTPN23 ARCN1 MED15 PALS1 SNW1 STEEP1 CTTN CNOT1 SNX1 | 9.02e-10 | 549 | 206 | 19 | 38280479 | |
| Pubmed | 1.20e-09 | 4 | 206 | 4 | 9770464 | ||
| Pubmed | UBR1 SRRM1 MYH9 SMC1A SPTAN1 UPF3B RBM25 ASCC2 KIF5B EBNA1BP2 GNAS MED12 WWC1 CUL1 RPL36 KIF21A SH3GL1 SMC4 ARCN1 MED15 PALS1 EEF2 SNW1 SF3B1 NEMF MARK2 ARHGEF2 CTTN | 1.62e-09 | 1247 | 206 | 28 | 27684187 | |
| Pubmed | MYH9 SLK SMC1A DHX38 FYCO1 RBM25 KIF5B PLCG1 EBNA1BP2 CUL1 SMC4 MAP7 IFIT1 ARCN1 EEF2 SNW1 SF3B1 WDR11 NEMF SNX1 | 2.59e-09 | 653 | 206 | 20 | 33742100 | |
| Pubmed | SRRM1 MYH9 MYH11 SPTAN1 RPS6KA3 UPF3B ALKBH5 NUP205 RBM25 MCM3AP ASCC2 KIF5B NKAP EBNA1BP2 GNAS CUL1 TASP1 PDCD7 ARCN1 FCF1 EEF2 SNW1 SF3B1 NEMF SMARCD1 SMARCD2 MARK2 ARHGEF2 CNOT1 | 3.09e-09 | 1371 | 206 | 29 | 36244648 | |
| Pubmed | The RSK2-RPS6 axis promotes axonal regeneration in the peripheral and central nervous systems. | 5.95e-09 | 5 | 206 | 4 | 37068088 | |
| Pubmed | 5.95e-09 | 5 | 206 | 4 | 24416220 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | SRRM1 MYH9 SMC1A SPTAN1 MRPL19 BCL7A NUP205 RBM25 CFAP45 PDS5A MED12 RPL36 KALRN PDCD7 INTS8 EEF2 SNW1 SF3B1 NEMF INTS4 SMARCD1 MACF1 SMARCD3 ARHGEF2 CNOT1 | 7.48e-09 | 1082 | 206 | 25 | 38697112 |
| Pubmed | MYH9 SLK MYH11 ATP6V0A1 TRIO SPTAN1 PSMC1 UPF3B ACTN2 ATAD3C MICAL3 KIF5B KIF5C PLEKHA7 MICAL1 RPL36 KALRN SH3GL1 CNKSR2 MAP7 ARCN1 EEF2 SF3B1 MCU MACF1 MARK2 ARHGEF2 CTTN CNOT1 | 7.99e-09 | 1431 | 206 | 29 | 37142655 | |
| Pubmed | SRRM1 MYH9 RPS6KA3 CABLES1 RBM25 TIMELESS KALRN MAP7 KAT7 EEF2 SF3B1 SMARCD2 MARK2 ARHGEF2 CTTN CDCA5 KIF1C | 1.02e-08 | 503 | 206 | 17 | 16964243 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | SRRM1 MYH9 MYH11 RNF168 SMC1A SPTAN1 UPF3B RBM25 KIF5B EBNA1BP2 GNAS CUL1 RPL36 MAP7D3 SMC4 MAP7 FCF1 EEF2 SF3B1 STEEP1 MARK2 ARHGEF2 CTTN | 1.30e-08 | 949 | 206 | 23 | 36574265 |
| Pubmed | PSMC1 MRPL19 RBM25 SLC7A6OS MCM3AP TIMELESS EBNA1BP2 TAFAZZIN GINS4 SPAG7 PDCD7 SF3B1 NEMF MPHOSPH6 SYVN1 CNOT1 | 1.43e-08 | 451 | 206 | 16 | 30033366 | |
| Pubmed | SRRM1 MYH9 SPTAN1 DHX38 NUP205 RBM25 MCM3AP PDS5A KIF5B EBNA1BP2 MED12 UBR4 SMC4 IARS2 SNW1 SF3B1 MACF1 CNOT1 STAG2 | 1.50e-08 | 653 | 206 | 19 | 22586326 | |
| Pubmed | 1.78e-08 | 6 | 206 | 4 | 12832467 | ||
| Pubmed | Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase. | 1.78e-08 | 6 | 206 | 4 | 8688081 | |
| Pubmed | 1.78e-08 | 6 | 206 | 4 | 11175347 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | SRRM1 MYH9 SLK SMC1A SPTAN1 PSMC1 AMOTL1 PDS5A MICAL3 KIF5B GNAS RPL36 SH3GL1 UBR4 SMC4 MAP7 ARCN1 PALS1 EEF2 SF3B1 NEMF MACF1 CTTN CNOT1 SNX5 | 2.42e-08 | 1149 | 206 | 25 | 35446349 |
| Pubmed | 2.59e-08 | 151 | 206 | 10 | 17043677 | ||
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | UBR1 SRRM1 MYH9 SMC1A UPF3B RBM25 ASCC2 EBNA1BP2 CUL1 SMC4 KAT7 EEF2 SNW1 SF3B1 NEMF SMARCD3 | 4.03e-08 | 486 | 206 | 16 | 30940648 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | PALD1 MYH9 SLK DHX38 UPF3B MCCC1 MRTFB KIF5B PLCG1 EBNA1BP2 MAP7D3 SH3GL1 PTPN23 SPAG7 ARCN1 IARS2 SNW1 SF3B1 STEEP1 MACF1 CTTN SNX1 | 4.54e-08 | 934 | 206 | 22 | 33916271 |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | MYH9 SLK SPTAN1 KIF5B MAP7D3 SMC4 MAP7 SNW1 SF3B1 STEEP1 CTTN SNX1 | 4.87e-08 | 256 | 206 | 12 | 33397691 |
| Pubmed | MYH11 SMC1A DHX38 SYTL2 RGL1 TLK1 ATAD3C PDS5A MICAL3 KAZN MED12 PTPN23 USP37 WDR11 MACF1 KIF1C | 4.90e-08 | 493 | 206 | 16 | 15368895 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | SRRM1 MYH2 MYH9 SMC1A DHX38 GAS8 PSMC1 NUP205 TLK1 RBM25 AMOTL1 PDS5A KIF5B KIF5C EBNA1BP2 GNAS CUL1 RPL36 UBR4 SMC4 CNKSR2 SF3B1 STEEP1 MARK2 ARHGEF2 CNOT1 | 5.20e-08 | 1284 | 206 | 26 | 17353931 |
| Pubmed | SRRM1 SLK MIS18BP1 SPTAN1 UPF3B CDYL MICAL3 KIF5B MED12 MAP7D3 SPAG7 MAP7 KIF7 MED15 KAT7 CNOT1 CDCA5 SNX1 | 6.82e-08 | 645 | 206 | 18 | 25281560 | |
| Pubmed | DHX38 PSMC1 BCL7A ALKBH5 UBXN4 MRTFB ASCC2 PDS5A CDYL NKAP PLEKHA7 MED12 RPL36 TASP1 SMC4 MAP7 PDCD7 INTS8 DNAJC2 MED15 PPP3CC WDR11 MACF1 MPHOSPH6 MARK2 ARHGEF2 STAG2 XPR1 | 7.96e-08 | 1497 | 206 | 28 | 31527615 | |
| Pubmed | 8.21e-08 | 8 | 206 | 4 | 21699228 | ||
| Pubmed | 8.21e-08 | 8 | 206 | 4 | 9829964 | ||
| Pubmed | SMC1A SPTAN1 AMOTL1 PLEKHA7 WWC1 KIF7 PALS1 SMARCD1 MARK2 ARHGEF2 CNOT1 TRIM37 SNX5 KIF1C XPR1 | 8.23e-08 | 446 | 206 | 15 | 24255178 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | SRRM1 SMC1A RPS6KA1 RPS6KA3 PSMC1 PTEN NUP205 FBXO22 PLCG1 EBNA1BP2 GNAS WWC1 DUSP5 SH3GL1 UBR4 SMC4 PTPN23 KIF7 SNW1 MARK2 CTTN XPR1 | 9.39e-08 | 974 | 206 | 22 | 28675297 |
| Pubmed | RNF168 DHX38 PSMC1 TLK1 FBXO22 BRCA2 ETAA1 MED12 NSMCE2 MED15 SF3B1 SMARCD1 SMARCD2 SMARCD3 TOP3A | 1.01e-07 | 453 | 206 | 15 | 29656893 | |
| Pubmed | SMG1 SLK SMC1A SPTAN1 PSMC1 PAGR1 MCCC1 BCL7A NUP205 HOXA10 RBM25 PDS5A EBNA1BP2 RPL36 UBR4 MAP7 SKI CREB1 KIF7 MED15 PALS1 SNW1 SMARCD1 SMARCD2 SMARCD3 CTTN CNOT1 | 1.14e-07 | 1429 | 206 | 27 | 35140242 | |
| Pubmed | 1.47e-07 | 9 | 206 | 4 | 17349791 | ||
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | MYH9 PSMC1 TLK1 RBM25 DIAPH2 CDYL KAZN WWC1 GALNT10 DEPTOR SH3GL1 MAP7 WDR11 MARK2 ARHGEF2 SNX5 | 1.53e-07 | 536 | 206 | 16 | 15840001 |
| Pubmed | MYH9 PSMC1 TLK1 RBM25 DIAPH2 CDYL KAZN WWC1 GALNT10 DEPTOR SH3GL1 MAP7 WDR11 MARK2 ARHGEF2 SNX5 | 1.60e-07 | 538 | 206 | 16 | 10512203 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | UBR1 SRRM1 MYH9 SLK PSMC1 MCCC1 NUP205 UBXN4 MRTFB KIF5B GNAS KIF21A SH3GL1 UBR4 SMC4 PTPN23 IFIT1 ARCN1 EEF2 IARS2 SNW1 SF3B1 STEEP1 CTTN CNOT1 SNX1 | 1.76e-07 | 1367 | 206 | 26 | 32687490 |
| Pubmed | SMC1A PSMC1 UPF3B ALKBH5 TLK1 PDS5A KIF5B MED12 CUL1 SMC4 SPAG7 CREB1 MED15 EEF2 SNW1 SBDS STEEP1 SMARCD1 SMARCD2 ARHGEF2 CNOT1 CDCA5 STAG2 | 1.95e-07 | 1103 | 206 | 23 | 34189442 | |
| Pubmed | 2.05e-07 | 3 | 206 | 3 | 12393804 | ||
| Pubmed | Expression analysis of Baf60c during heart regeneration in axolotls and neonatal mice. | 2.05e-07 | 3 | 206 | 3 | 27125315 | |
| Pubmed | 2.05e-07 | 3 | 206 | 3 | 26977024 | ||
| Pubmed | Human rsk isoforms: cloning and characterization of tissue-specific expression. | 2.05e-07 | 3 | 206 | 3 | 8141249 | |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | MYH11 ATP6V0A1 RPS6KA1 RPS6KA2 SPTAN1 MCCC1 ADCY6 ITIH1 BRCA2 KIF5B KIF5C GNAS KIF21A SH3GL1 EEF2 MARK2 ARHGEF2 | 2.10e-07 | 621 | 206 | 17 | 22794259 |
| Pubmed | Scc1 sumoylation by Mms21 promotes sister chromatid recombination through counteracting Wapl. | 2.44e-07 | 10 | 206 | 4 | 22751501 | |
| Pubmed | 2.44e-07 | 10 | 206 | 4 | 23242214 | ||
| Pubmed | 2.56e-07 | 147 | 206 | 9 | 16959763 | ||
| Pubmed | PALD1 MYH9 SMC1A PSMC1 RBM25 PDS5A MICAL3 KIF5B MED12 MAP7D3 SMC4 PTPN23 ARCN1 EEF2 MACF1 MARK2 CTTN CNOT1 | 2.69e-07 | 708 | 206 | 18 | 39231216 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | MYH9 SLK SPTAN1 MRTFB KIF5B EBNA1BP2 PLEKHA7 EPN3 SH3GL1 EEF2 STXBP6 MACF1 MARK2 CTTN SNX1 SNX5 | 3.09e-07 | 565 | 206 | 16 | 25468996 |
| Pubmed | SRRM1 MYH9 DHX38 PAGR1 NUP205 TLK1 GCLC SLC7A6OS MCM3AP PLCG1 NKAP MED12 TAFAZZIN RPL36 UBR4 SPAG7 CREB1 CREM KAT7 SNW1 SBDS STEEP1 SMARCD1 SYVN1 CNOT1 | 3.69e-07 | 1327 | 206 | 25 | 32694731 | |
| Pubmed | Wapl controls the dynamic association of cohesin with chromatin. | 3.82e-07 | 11 | 206 | 4 | 17113138 | |
| Pubmed | MYH9 RPS6KA1 MRPL19 ALKBH5 RBM25 UBXN4 MRTFB PTPN23 MED15 NEMF | 3.96e-07 | 202 | 206 | 10 | 29540532 | |
| Pubmed | UBR1 SMG1 SLK RPS6KA1 DHX38 COLGALT2 ADCY6 DIAPH2 MICAL3 TIMELESS PALS1 WDR11 MCU NEMF MARK2 ARHGEF2 TOP3A | 3.96e-07 | 650 | 206 | 17 | 38777146 | |
| Pubmed | SRRM1 MYH9 SMC1A SPTAN1 HOXA10 RBM25 KIF5B EBNA1BP2 MAP7D3 SH3GL1 SMC4 EEF2 SNW1 SF3B1 | 4.50e-07 | 441 | 206 | 14 | 31239290 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | MIS18BP1 DHX38 UPF3B MCCC1 ALKBH5 MRTFB BRCA2 MCM3AP GNAS CUL1 MAP7 CREB1 MACF1 CFAP44 TRIM37 TOP3A | 5.24e-07 | 588 | 206 | 16 | 38580884 |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | SRRM1 SMC1A RPS6KA3 PSMC1 ACTN2 RBM25 ATAD3C NKAP EBNA1BP2 GNAS UBR4 XBP1 PTPN23 ARCN1 DNAJC2 CTTN CNOT1 | 5.43e-07 | 665 | 206 | 17 | 30457570 |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | SMG1 SRRM1 MYH2 MYH3 SLK ATP6V0A1 TRIO RPS6KA1 RPS6KA2 RPS6KA3 UPF3B CABLES1 RIN2 PLCG1 NKAP CUL1 KAT7 MARK2 ARHGEF2 CTTN | 5.70e-07 | 910 | 206 | 20 | 36736316 |
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 6.16e-07 | 212 | 206 | 10 | 33853758 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | MYH2 MYH9 SLK SMC1A DHX38 PSMC1 UPF3B NUP205 FBXO22 AMOTL1 KIF5B PLEKHA7 CUL1 CNKSR2 USP37 ARCN1 KIF7 PALS1 MARK2 ARHGEF2 CNOT1 | 6.62e-07 | 1005 | 206 | 21 | 19615732 |
| Pubmed | 7.31e-07 | 216 | 206 | 10 | 31519766 | ||
| Pubmed | ATP6V0A1 PDE9A TRIO SMC1A SPTAN1 PSMC1 OTOF PLCG1 KIF5C KALRN KIF21A UBR4 PDCD7 INTS8 ARCN1 EEF2 SF3B1 PPP3CB NEMF MACF1 CTTN TRIM37 SNX1 SNX5 | 7.50e-07 | 1285 | 206 | 24 | 35914814 | |
| Pubmed | SMC1A SPTAN1 PDS5A MED12 UBR4 MAP7 SNW1 SF3B1 SMARCD1 CDCA5 STAG2 | 7.72e-07 | 272 | 206 | 11 | 31010829 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | SMC1A SPTAN1 RPS6KA3 PSMC1 PDS5A KIF5B UBR4 SMC4 EEF2 SNW1 SF3B1 STAG2 | 7.92e-07 | 332 | 206 | 12 | 32786267 |
| Pubmed | Calcineurin inhibits Na+/Ca2+ exchange in phenylephrine-treated hypertrophic cardiomyocytes. | 8.16e-07 | 4 | 206 | 3 | 15557343 | |
| Pubmed | Proteomic analysis of NMDA receptor-adhesion protein signaling complexes. | 8.35e-07 | 86 | 206 | 7 | 10862698 | |
| Pubmed | MYH9 SLK TRIO SPTAN1 PSMC1 UPF3B ALKBH5 FBXO22 PDS5A CDYL EBNA1BP2 GNAS MAP7D3 KIF21A UBR4 SMC4 PTPN23 MAP7 EEF2 SF3B1 NEMF MACF1 CNOT1 SNX1 | 8.83e-07 | 1297 | 206 | 24 | 33545068 | |
| Pubmed | MYH9 SMC1A SPTAN1 PSMC1 EBNA1BP2 CUL1 RPL36 SH3GL1 SMC4 ARCN1 EEF2 SF3B1 STEEP1 MACF1 CTTN | 8.88e-07 | 538 | 206 | 15 | 28524877 | |
| Pubmed | CHK2 kinase promotes pre-mRNA splicing via phosphorylating CDK11(p110). | 9.14e-07 | 55 | 206 | 6 | 23178491 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | UBR1 SRRM1 SMC1A SPTAN1 PAGR1 ADCY6 TLK1 RBM25 MICAL3 TIMELESS NKAP CLASRP EEF2 SF3B1 MARK2 ARHGEF2 CTTN STAG2 | 9.70e-07 | 774 | 206 | 18 | 15302935 |
| Pubmed | MYH9 MYH11 SMC1A SPTAN1 RBM25 PDS5A CUL1 SMC4 SF3B1 ARHGEF2 CTTN TOP3A | 1.02e-06 | 340 | 206 | 12 | 24332808 | |
| Pubmed | 1.14e-06 | 14 | 206 | 4 | 9687510 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | TACO1 DHX38 PSMC1 NUP205 PDS5A TIMELESS KIF5B PLCG1 KIF5C DNAH8 UBR4 SMC4 PTPN23 ARCN1 IARS2 SMARCD2 CNOT1 | 1.18e-06 | 704 | 206 | 17 | 29955894 |
| Pubmed | SRRM1 TRIO BRCA2 RIN2 PDS5A EBNA1BP2 PLEKHA7 UBR4 IARS2 SBDS MCU SMARCD1 MACF1 SMARCD2 SMARCD3 SNX5 | 1.40e-06 | 634 | 206 | 16 | 34591612 | |
| Pubmed | SYNPO2 MYH9 MYH11 SPTAN1 RGL1 TLK1 MCM3AP DIAPH2 KIF5B PTPN23 CREB1 SF3B1 CEP250 MACF1 | 1.42e-06 | 486 | 206 | 14 | 20936779 | |
| Pubmed | 1.55e-06 | 15 | 206 | 4 | 23901111 | ||
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | 1.57e-06 | 235 | 206 | 10 | 30258100 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | SMC1A DHX38 BCL7A TLK1 PDS5A MICAL3 TIMELESS NKAP EBNA1BP2 GNAS NSMCE2 ARCN1 SNW1 SF3B1 SMARCD1 SMARCD2 MARK2 CNOT1 CDCA5 STAG2 TOP3A KIF1C | 1.63e-06 | 1155 | 206 | 22 | 20360068 |
| Pubmed | MYH9 ATP6V0A1 SMC1A RPS6KA3 PSMC1 KIF5B KIF5C GNAS RPL36 WNT7B SMC4 INTS8 IFIT1 ARCN1 EEF2 IARS2 SBDS NEMF | 1.63e-06 | 803 | 206 | 18 | 36517590 | |
| Pubmed | MYH9 SMC1A SPTAN1 PSMC1 NUP205 BRCA2 PDS5A GNAS RPL36 SMC4 EEF2 SNW1 SF3B1 CDCA5 STAG2 TOP3A | 2.00e-06 | 652 | 206 | 16 | 31180492 | |
| Pubmed | 2.03e-06 | 5 | 206 | 3 | 9693044 | ||
| Pubmed | 2.03e-06 | 5 | 206 | 3 | 10480933 | ||
| Pubmed | 2.03e-06 | 5 | 206 | 3 | 16217014 | ||
| Pubmed | 2.03e-06 | 5 | 206 | 3 | 9915826 | ||
| Pubmed | 2.03e-06 | 5 | 206 | 3 | 15867353 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | MYH3 MYH9 PSMC1 CABLES1 NUP205 ZFR2 MCM3AP PDS5A KAZN IQCE KIF21A UBR4 DNAH2 SMC4 ARCN1 CFAP44 CNOT1 | 2.15e-06 | 736 | 206 | 17 | 29676528 |
| Pubmed | SMG1 ZMYND11 RNF168 SYTL2 MRTFB MCM3AP ASCC2 EPN3 UBR4 SKI PDCD7 SF3B1 CEP250 CSPG4 MACF1 | 2.81e-06 | 591 | 206 | 15 | 15231748 | |
| Pubmed | SMC1A PSMC1 UPF3B CABLES1 PLEKHA7 KIF7 ARHGEF2 CNOT1 SNX5 KIF1C | 2.83e-06 | 251 | 206 | 10 | 29778605 | |
| Pubmed | SLK TRIO RPS6KA2 SPTAN1 KIF5C KALRN GRIA4 CNKSR2 PPP3CB MACF1 | 2.83e-06 | 251 | 206 | 10 | 27507650 | |
| Interaction | CDC5L interactions | SRRM1 MYH9 SLK TRIO SMC1A SPTAN1 DHX38 PSMC1 SFI1 KIF5B GNAS WWC1 CUL1 KALRN KIF21A SMC4 MAP7 INTS8 ARCN1 SNW1 SF3B1 STEEP1 SMARCD1 MACF1 MARK2 ARHGEF2 CNOT1 STAG2 | 3.14e-08 | 855 | 201 | 28 | int:CDC5L |
| Interaction | RAD21 interactions | SRRM1 SMC1A RPS6KA1 TRAIP PSMC1 PTEN BRCA2 PDS5A SH3GL1 SMC4 USP37 NSMCE2 SNW1 CTTN CDCA5 STAG2 TOP3A | 3.33e-07 | 384 | 201 | 17 | int:RAD21 |
| Interaction | MECP2 interactions | TACO1 SRRM1 MYH9 SMC1A SPTAN1 MRPL19 BCL7A NUP205 RBM25 CFAP45 PDS5A MED12 RPL36 KALRN SKI PDCD7 INTS8 CREB1 FCF1 EEF2 SNW1 SF3B1 NEMF INTS4 SMARCD1 MACF1 SMARCD2 SMARCD3 ARHGEF2 CTTN CNOT1 SNX1 TOP3A | 5.24e-07 | 1287 | 201 | 33 | int:MECP2 |
| Interaction | NINL interactions | MIS18BP1 PSMC1 BRCA2 MICAL3 NKAP PLEKHA7 CCDC33 MAP7D3 SMC4 CCDC57 KIF7 KAT7 PALS1 CBY2 CEP250 CNOT1 TRIM37 L3MBTL4 | 8.41e-07 | 458 | 201 | 18 | int:NINL |
| Interaction | CIT interactions | SRRM1 MYH9 MYH11 SMC1A SPTAN1 DHX38 UPF3B ACTN2 PTEN NUP205 RBM25 FBXO22 ATAD3C PDS5A CDYL EBNA1BP2 GNAS WWC1 RPL36 KALRN UBR4 SMC4 MAP7 PDCD7 KAT7 EEF2 SNW1 SF3B1 MCU INTS4 MACF1 SMARCD2 MPHOSPH6 ARHGEF2 STAG2 | 9.22e-07 | 1450 | 201 | 35 | int:CIT |
| Interaction | PHLPP1 interactions | MYH9 SLK SPTAN1 FBXO22 KIF5B MAP7D3 SMC4 MAP7 SNW1 SF3B1 MCU STEEP1 MARK2 CTTN SNX1 | 1.35e-06 | 333 | 201 | 15 | int:PHLPP1 |
| Interaction | YAP1 interactions | MYH9 SLK MYH11 SPTAN1 PTEN RBM25 MRTFB AMOTL1 KIF5B GNAS MED12 TAFAZZIN WWC1 RPL36 MAP7D3 SH3GL1 SMC4 CNKSR2 CREB1 MED15 PALS1 EEF2 SNW1 STEEP1 SMARCD1 CTTN CNOT1 TRIM37 SNX1 | 1.48e-06 | 1095 | 201 | 29 | int:YAP1 |
| Interaction | EFTUD2 interactions | SRRM1 ZMYND11 MYH9 SLK SMC1A SPTAN1 DHX38 PSMC1 UPF3B PTEN FBXO22 SLC7A6OS PDS5A KIF5B EBNA1BP2 MED12 RPL36 KIF21A SH3GL1 UBR4 SMC4 MAP7 USP37 ARCN1 DNAJC2 EEF2 SNW1 SF3B1 NEMF MACF1 ARHGEF2 STAG2 SNX1 KIF1C | 2.54e-06 | 1449 | 201 | 34 | int:EFTUD2 |
| Interaction | MAPRE3 interactions | TRIO TRAIP MAP7D3 KIF21A MAP7 KIF7 IARS2 SF3B1 MACF1 MARK2 ARHGEF2 KIF1C | 3.57e-06 | 230 | 201 | 12 | int:MAPRE3 |
| Interaction | LZTS2 interactions | MYH9 MIS18BP1 SPTAN1 CABLES1 BRCA2 KAZN PLCG1 PLEKHA7 MED12 IQCE DUSP5 KIF7 IARS2 SNW1 CEP250 SMARCD1 CNOT1 TRIM37 | 4.05e-06 | 512 | 201 | 18 | int:LZTS2 |
| Interaction | CALM1 interactions | MYH9 SFI1 PTEN NEUROD1 MCM3AP SCN5A GNAS IQCE CUL1 MAP7D3 SH3GL1 UBR4 PDCD7 OPRM1 SNW1 SF3B1 PPP3CB PPP3CC MYBPC1 KIF1C | 4.89e-06 | 626 | 201 | 20 | int:CALM1 |
| Interaction | DISC1 interactions | TRIO SPTAN1 DHX38 GAS8 COLGALT2 ACTN2 TIAM2 PLCG1 KALRN CCDC57 KIF7 EEF2 WDR11 SMARCD1 MACF1 TRIM37 | 6.80e-06 | 429 | 201 | 16 | int:DISC1 |
| Interaction | MYH9 interactions | MYH9 MYH11 SPTAN1 PSMC1 ASCC2 MICAL3 KIF5B PLCG1 GNAS CUL1 SMC4 GRIA4 CCDC57 ARCN1 FCF1 IARS2 SNW1 CEP250 MACF1 SYVN1 CTTN TRIM37 | 6.85e-06 | 754 | 201 | 22 | int:MYH9 |
| Interaction | CAV3 interactions | 6.85e-06 | 71 | 201 | 7 | int:CAV3 | |
| Interaction | TOP3B interactions | PALD1 TRIO SMC1A RPS6KA2 SPTAN1 PANX1 FYCO1 SFI1 BCL7A TIAM2 CABLES1 TLK1 FBXO22 MCM3AP SCN5A DIAPH2 MICAL3 PLCG1 GNAS MED12 IQCE EPN3 KALRN WNT7B DUSP5 UBR4 TASP1 KLHL25 CSPG4 ARHGEF2 SYVN1 CNOT1 TOP3A | 9.25e-06 | 1470 | 201 | 33 | int:TOP3B |
| Interaction | WAPL interactions | SRRM1 SMC1A FBXO22 PDS5A USP37 NSMCE2 SNW1 SF3B1 CDCA5 STAG2 | 9.66e-06 | 173 | 201 | 10 | int:WAPL |
| Interaction | HERC2 interactions | SRRM1 RNF168 PDE9A PSMC1 RBM25 ETAA1 KIF5B KIF5C NKAP GNAS UBR4 MAP7 CEP250 MACF1 MARK2 CNOT1 TOP3A | 1.26e-05 | 503 | 201 | 17 | int:HERC2 |
| Interaction | KIF23 interactions | SRRM1 MYH9 MYH11 SPTAN1 DHX38 PSMC1 MRPL19 FYCO1 PTEN RBM25 ATAD3C MICAL3 EBNA1BP2 GNAS CUL1 MICAL1 RPL36 SMC4 EEF2 SF3B1 WDR11 CEP250 MACF1 ARHGEF2 STAG2 TRIM37 | 1.30e-05 | 1031 | 201 | 26 | int:KIF23 |
| Interaction | SNRNP200 interactions | SRRM1 ZMYND11 SMC1A DHX38 PTEN SLC7A6OS PDS5A MED12 UBR4 USP37 PDCD7 SNW1 SF3B1 SBDS CDCA5 STAG2 | 1.62e-05 | 460 | 201 | 16 | int:SNRNP200 |
| Interaction | STAG2 interactions | SRRM1 SMC1A PTEN PDS5A MAP7 USP37 NSMCE2 OPRM1 SF3B1 CDCA5 STAG2 | 1.62e-05 | 224 | 201 | 11 | int:STAG2 |
| Interaction | GSK3A interactions | SRRM1 TRIO RBM25 MICAL3 EBNA1BP2 WWC1 MAP7D3 KIF21A MAP7 CREB1 CREM SNW1 PPP3CB PPP3CC MACF1 MARK2 | 1.80e-05 | 464 | 201 | 16 | int:GSK3A |
| Interaction | KBTBD4 interactions | SMG1 MYH9 MCCC1 PTEN MRTFB RPL36 MAP7D3 UBR4 SMC4 SNW1 MCU STEEP1 CTTN | 1.83e-05 | 316 | 201 | 13 | int:KBTBD4 |
| Interaction | CCDC175 interactions | 1.91e-05 | 6 | 201 | 3 | int:CCDC175 | |
| Interaction | SNW1 interactions | SRRM1 MYH9 SMC1A SPTAN1 DHX38 PSMC1 ACTN2 ASCC2 EBNA1BP2 CUL1 KIF21A SMC4 SKI ARCN1 SNW1 SF3B1 STEEP1 ARHGEF2 CTTN CNOT1 TRIM37 | 1.95e-05 | 747 | 201 | 21 | int:SNW1 |
| Interaction | GSK3B interactions | UBR1 MYH9 TRIO RPS6KA1 PSMC1 NUP205 MICAL3 KIF5B TAFAZZIN WWC1 MICAL1 MAP7D3 MAP7 CREB1 CREM ARCN1 EEF2 IARS2 SF3B1 PPP3CC MACF1 MARK2 CTTN | 1.97e-05 | 868 | 201 | 23 | int:GSK3B |
| Interaction | BRD7 interactions | UBR1 SRRM1 MYH9 SMC1A UPF3B BCL7A RBM25 ASCC2 EBNA1BP2 CUL1 SMC4 KAT7 EEF2 SNW1 SF3B1 NEMF SMARCD1 SMARCD2 SMARCD3 | 2.22e-05 | 637 | 201 | 19 | int:BRD7 |
| Interaction | PLEC interactions | MYH9 SLK SPTAN1 PTEN BRCA2 MCM3AP KAZN SMC4 SKI SNW1 SBDS MACF1 SYVN1 CTTN TRIM37 | 2.89e-05 | 430 | 201 | 15 | int:PLEC |
| Interaction | TNIK interactions | TRIO SPTAN1 TIAM2 KIF5B KIF5C WWC1 KALRN CNKSR2 DNAJC2 KIF7 PALS1 PPP3CB MACF1 ARHGEF2 | 3.05e-05 | 381 | 201 | 14 | int:TNIK |
| Interaction | ATM interactions | SMC1A RPS6KA1 RPS6KA3 PTEN FBXO22 BRCA2 WWC1 USP37 CREB1 OPRM1 SNW1 CTTN TRIM37 | 3.16e-05 | 333 | 201 | 13 | int:ATM |
| Interaction | H3C1 interactions | ZMYND11 MYH9 SMC1A SPTAN1 RPS6KA3 DHX38 TLK1 PDS5A CDYL EBNA1BP2 DNAH8 WWC1 RPL36 UBR4 DNAH2 SPAG7 CREB1 KAT7 SNW1 SF3B1 STEEP1 CDCA5 STAG2 | 3.53e-05 | 901 | 201 | 23 | int:H3C1 |
| Interaction | LTN1 interactions | MYH9 RPS6KA1 RPS6KA2 RPS6KA3 MRPL19 MRTFB MCM3AP RPS6KA6 TET3 NEMF | 3.53e-05 | 201 | 201 | 10 | int:LTN1 |
| Interaction | RHOB interactions | PALD1 SLK TRIO SPTAN1 PSMC1 PANX1 UPF3B ADCY6 TIAM2 CABLES1 NUP205 DIAPH2 MICAL3 GNAS PLEKHA7 SH3GL1 PALS1 MCU MACF1 MARK2 ARHGEF2 XPR1 | 3.60e-05 | 840 | 201 | 22 | int:RHOB |
| Interaction | SEM1 interactions | 3.71e-05 | 162 | 201 | 9 | int:SEM1 | |
| Interaction | IRGC interactions | 4.11e-05 | 20 | 201 | 4 | int:IRGC | |
| Interaction | EED interactions | SRRM1 MYH9 MYH11 ATP6V0A1 TRIO SMC1A RPS6KA1 SPTAN1 PSMC1 PTEN NUP205 RBM25 PDS5A KIF5B EBNA1BP2 CUL1 RPL36 UBR4 SMC4 INTS8 ARCN1 CLASRP FCF1 EEF2 SF3B1 SMARCD1 MACF1 MARK2 CTTN CNOT1 STAG2 | 4.27e-05 | 1445 | 201 | 31 | int:EED |
| Interaction | DDRGK1 interactions | SRRM1 MYH9 MYH11 PSMC1 PANX1 UPF3B ALKBH5 NUP205 RBM25 ASCC2 PDS5A NKAP EBNA1BP2 RPL36 UBR4 SMC4 MAP7 ARCN1 FCF1 EEF2 SNW1 SF3B1 WDR11 NEMF MPHOSPH6 MARK2 ARHGEF2 SYVN1 | 4.91e-05 | 1249 | 201 | 28 | int:DDRGK1 |
| Interaction | CAMSAP2 interactions | 5.16e-05 | 169 | 201 | 9 | int:CAMSAP2 | |
| Interaction | SHANK1 interactions | 5.26e-05 | 41 | 201 | 5 | int:SHANK1 | |
| Interaction | SP7 interactions | SMC1A GAS8 PAGR1 BCL7A NUP205 HOXA10 RBM25 EBNA1BP2 CUL1 SMARCD1 SMARCD2 SMARCD3 | 5.75e-05 | 304 | 201 | 12 | int:SP7 |
| Interaction | NIN interactions | TRIO MBD3L2 NUP205 BRCA2 MAP7D3 CCDC57 ARCN1 KIF7 SNW1 CEP250 MCU ARHGEF2 CTTN | 6.83e-05 | 359 | 201 | 13 | int:NIN |
| Interaction | ACACA interactions | MYH9 RPS6KA1 DHX38 PSMC1 UPF3B MCCC1 PTEN NUP205 FBXO22 KIF5B SMC4 SPAG7 IFIT1 KAT7 SBDS | 7.37e-05 | 467 | 201 | 15 | int:ACACA |
| Interaction | HTT interactions | MYH11 ATP6V0A1 RPS6KA1 RPS6KA2 SPTAN1 ACTN2 MCCC1 ADCY6 ITIH1 RBM25 NEUROD1 BRCA2 KIF5B KIF5C GNAS KIF21A SH3GL1 CREB1 OPRM1 EEF2 MARK2 ARHGEF2 SYVN1 | 7.77e-05 | 949 | 201 | 23 | int:HTT |
| Interaction | SMARCB1 interactions | SPTAN1 BCL7A PTEN RBM25 FBXO22 BRCA2 CDYL CCDC33 DEPTOR SMC4 SMARCD1 SMARCD2 SMARCD3 | 7.85e-05 | 364 | 201 | 13 | int:SMARCB1 |
| Interaction | STAG1 interactions | 8.30e-05 | 104 | 201 | 7 | int:STAG1 | |
| Interaction | PARD3B interactions | 9.23e-05 | 46 | 201 | 5 | int:PARD3B | |
| Interaction | HSP90AB1 interactions | MYH9 SMC1A RPS6KA1 SPTAN1 RPS6KA3 PTEN BRCA2 PLCG1 TET3 CUL1 UBR4 DNAH2 TASP1 SKI IFIT1 EEF2 IARS2 SNW1 CEP250 MARK2 MAPK4 SYVN1 TRIM37 | 9.23e-05 | 960 | 201 | 23 | int:HSP90AB1 |
| Interaction | NAA40 interactions | PALD1 MYH9 SLK DHX38 UPF3B MCCC1 MRTFB KIF5B PLCG1 EBNA1BP2 MAP7D3 SH3GL1 PTPN23 SPAG7 ARCN1 IARS2 SNW1 SF3B1 WDR11 STEEP1 MACF1 CTTN SNX1 | 1.22e-04 | 978 | 201 | 23 | int:NAA40 |
| Interaction | ARL10 interactions | 1.22e-04 | 189 | 201 | 9 | int:ARL10 | |
| Interaction | SNAI1 interactions | MYH9 SMC1A SPTAN1 PSMC1 ACTN2 PTEN NUP205 RBM25 FBXO22 CUL1 SMC4 USP37 EEF2 SF3B1 INTS4 TOP3A | 1.24e-04 | 546 | 201 | 16 | int:SNAI1 |
| Interaction | KCTD13 interactions | MYH9 SLK MYH11 ATP6V0A1 TRIO SPTAN1 PSMC1 UPF3B ACTN2 MICAL3 KIF5B KIF5C PLEKHA7 MICAL1 RPL36 KALRN SH3GL1 CNKSR2 MAP7 ARCN1 KAT7 EEF2 SF3B1 MCU MACF1 MARK2 ARHGEF2 CTTN CNOT1 | 1.33e-04 | 1394 | 201 | 29 | int:KCTD13 |
| Interaction | SQSTM1 interactions | SMG1 SYNPO2 SLK RNF168 TRIO PSMC1 UPF3B ALKBH5 AMOTL1 KIF5B NKAP CUL1 DEPTOR MAP7D3 SMC4 MAP7 SKI KIF7 MED15 EEF2 IARS2 CEP250 STEEP1 SMARCD1 CTTN CNOT1 TRIM37 | 1.38e-04 | 1257 | 201 | 27 | int:SQSTM1 |
| Interaction | FRK interactions | 1.38e-04 | 50 | 201 | 5 | int:FRK | |
| Interaction | LATS1 interactions | SRRM1 MYH2 MYH3 SPTAN1 PTEN AMOTL1 TAFAZZIN WWC1 CUL1 KIF7 PALS1 SF3B1 CBY2 MYBPC1 | 1.42e-04 | 440 | 201 | 14 | int:LATS1 |
| Interaction | DCTN1 interactions | RNF168 UPF3B MCCC1 EBNA1BP2 WWC1 MAP7D3 SMC4 MAP7 KIF7 SNW1 MACF1 MARK2 ARHGEF2 SNX1 SNX5 | 1.47e-04 | 497 | 201 | 15 | int:DCTN1 |
| Interaction | NCL interactions | SRRM1 ZMYND11 MYH9 RNF168 SMC1A TRAIP SPTAN1 RPS6KA3 BRCA2 EBNA1BP2 CUL1 RPL36 UBR4 SKI IFIT1 DNAJC2 EEF2 SBDS STAG2 TRIM37 | 1.50e-04 | 798 | 201 | 20 | int:NCL |
| Interaction | GRIN1 interactions | 1.60e-04 | 154 | 201 | 8 | int:GRIN1 | |
| Interaction | DHX15 interactions | SRRM1 RNF168 PSMC1 PTEN KIF5B NKAP EBNA1BP2 CUL1 RPL36 USP37 SNW1 SF3B1 CEP250 NEMF CDCA5 | 1.63e-04 | 502 | 201 | 15 | int:DHX15 |
| Interaction | SIRT7 interactions | SRRM1 MYH9 SPTAN1 DHX38 NUP205 RBM25 MCM3AP PDS5A KIF5B EBNA1BP2 MED12 UBR4 SMC4 IARS2 SNW1 SF3B1 MACF1 CNOT1 STAG2 | 1.74e-04 | 744 | 201 | 19 | int:SIRT7 |
| Interaction | KCNA3 interactions | PALD1 SRRM1 MYH9 SMC1A SYTL2 PSMC1 FYCO1 RBM25 PDS5A MICAL3 KIF5B MED12 MAP7D3 SMC4 PTPN23 ARCN1 EEF2 MACF1 MARK2 CTTN CNOT1 | 1.74e-04 | 871 | 201 | 21 | int:KCNA3 |
| Interaction | MLH1 interactions | 1.77e-04 | 244 | 201 | 10 | int:MLH1 | |
| Interaction | MED4 interactions | SRRM1 SLK MYH11 SPTAN1 MICAL3 KIF5B MED12 MAP7D3 KIF7 MED15 SMARCD1 SMARCD2 CNOT1 SNX1 | 1.79e-04 | 450 | 201 | 14 | int:MED4 |
| Interaction | FBXW7 interactions | SRRM1 MYH9 SMC1A PTEN HOXA10 EBNA1BP2 PLEKHA7 MED12 CUL1 RPL36 DEPTOR UBR4 XBP1 GINS4 ARCN1 MED15 KAT7 EEF2 IARS2 SF3B1 NEMF MACF1 ARHGEF2 TOP3A SNX5 KIF1C | 1.96e-04 | 1215 | 201 | 26 | int:FBXW7 |
| Interaction | TNIP1 interactions | SRRM1 MYH9 MYH11 RNF168 SMC1A SPTAN1 UPF3B RBM25 ATAD3C KIF5B EBNA1BP2 GNAS CUL1 RPL36 MAP7D3 SMC4 PTPN23 MAP7 OPRM1 FCF1 EEF2 SF3B1 STEEP1 MARK2 ARHGEF2 CTTN | 2.01e-04 | 1217 | 201 | 26 | int:TNIP1 |
| Interaction | ARHGAP26 interactions | 2.03e-04 | 120 | 201 | 7 | int:ARHGAP26 | |
| Interaction | PRKDC interactions | SRRM1 SMC1A RPS6KA2 DHX38 PTEN TIAM2 RBM25 PDS5A CUL1 SKI CREM SNW1 SF3B1 SBDS MAPK4 CDCA5 STAG2 TRIM37 | 2.18e-04 | 695 | 201 | 18 | int:PRKDC |
| Interaction | HNRNPC interactions | SPTAN1 PTEN BRCA2 CCDC33 CUL1 RPL36 MAP7 USP37 IFIT1 SNW1 SF3B1 CEP250 SMARCD1 SMARCD2 CDCA5 TRIM37 SNX1 | 2.18e-04 | 634 | 201 | 17 | int:HNRNPC |
| Interaction | AURKB interactions | SRRM1 MYH9 MYH11 SMC1A NUP205 TLK1 ATAD3C BRCA2 TIMELESS KIF5B CUL1 RPL36 UBR4 USP37 SNW1 SF3B1 MACF1 MARK2 CNOT1 | 2.31e-04 | 761 | 201 | 19 | int:AURKB |
| Interaction | SMARCA4 interactions | ZMYND11 BCL7A PTEN RBM25 NEUROD1 CDYL CUL1 CREB1 EEF2 SMARCD1 SMARCD2 SMARCD3 MPHOSPH6 CTTN | 2.34e-04 | 462 | 201 | 14 | int:SMARCA4 |
| Interaction | AMHR2 interactions | 2.37e-04 | 56 | 201 | 5 | int:AMHR2 | |
| Interaction | SMC3 interactions | SRRM1 MYH11 SMC1A PTEN FBXO22 BRCA2 PDS5A USP37 NSMCE2 SNW1 SF3B1 CDCA5 STAG2 | 2.42e-04 | 408 | 201 | 13 | int:SMC3 |
| Interaction | WFDC5 interactions | 2.60e-04 | 13 | 201 | 3 | int:WFDC5 | |
| Interaction | GSPT1 interactions | 2.64e-04 | 306 | 201 | 11 | int:GSPT1 | |
| Interaction | BAP1 interactions | SRRM1 MYH9 SLK SMC1A SPTAN1 PSMC1 PTEN BRCA2 AMOTL1 PDS5A MICAL3 KIF5B GNAS RPL36 SH3GL1 UBR4 SMC4 MAP7 ARCN1 PALS1 EEF2 SF3B1 NEMF MACF1 CTTN CNOT1 SNX5 | 2.81e-04 | 1314 | 201 | 27 | int:BAP1 |
| Interaction | FLNA interactions | SYNPO2 MYH9 MYH11 TRIO SPTAN1 PTEN BRCA2 PDS5A KIF5B GNAS OPRM1 EEF2 SNW1 SYVN1 CTTN CDCA5 STAG2 | 2.82e-04 | 648 | 201 | 17 | int:FLNA |
| Interaction | MKI67 interactions | SMG1 MYH3 RNF168 SMC1A TRAIP PTEN BRCA2 RPS6KA6 PDS5A MED12 DNAH2 ARCN1 SNW1 SMARCD2 MARK2 STAG2 TRIM37 | 2.82e-04 | 648 | 201 | 17 | int:MKI67 |
| Interaction | CEBPA interactions | MYH9 SMC1A SPTAN1 PSMC1 UPF3B ALKBH5 TLK1 PDS5A KIF5B MED12 CUL1 SMC4 SPAG7 CREB1 MED15 EEF2 SNW1 SBDS STEEP1 SMARCD1 MACF1 SMARCD2 ARHGEF2 CNOT1 CDCA5 STAG2 | 2.87e-04 | 1245 | 201 | 26 | int:CEBPA |
| Interaction | AMOT interactions | SMC1A PTEN AMOTL1 WWC1 UBR4 KIF7 PALS1 CEP250 CTTN MYBPC1 XPR1 | 3.12e-04 | 312 | 201 | 11 | int:AMOT |
| Interaction | EMID1 interactions | 3.13e-04 | 33 | 201 | 4 | int:EMID1 | |
| Interaction | GRIN2B interactions | 3.14e-04 | 170 | 201 | 8 | int:GRIN2B | |
| Interaction | WWTR1 interactions | SLK SPTAN1 HOXA10 RBM25 AMOTL1 KIF5B CUL1 PTPN23 ARCN1 PALS1 STEEP1 CNOT1 SNX1 | 3.34e-04 | 422 | 201 | 13 | int:WWTR1 |
| Interaction | YWHAQ interactions | MYH2 MYH9 SLK MYH11 RPS6KA1 RPS6KA3 ACTN2 MCCC1 KIF5B KIF5C PLEKHA7 WWC1 MAP7D3 MAP7 EEF2 SLC8A1 IARS2 SLC8A3 CEP250 MACF1 MARK2 ARHGEF2 TRIM37 KIF1C | 3.36e-04 | 1118 | 201 | 24 | int:YWHAQ |
| Interaction | SPDL1 interactions | PALD1 MYH9 MYH11 SPTAN1 DIAPH2 CUL1 RPL36 SMC4 SF3B1 SYVN1 STAG2 | 3.38e-04 | 315 | 201 | 11 | int:SPDL1 |
| Interaction | CRTC2 interactions | 3.55e-04 | 61 | 201 | 5 | int:CRTC2 | |
| Interaction | TRRAP interactions | MYH9 SMC1A RPS6KA1 SPTAN1 TIAM2 FBXO22 BRCA2 CACNA1G TIMELESS EBNA1BP2 MED12 WWC1 CUL1 DNAH2 HES3 IFIT1 MED15 SMARCD3 STAG2 | 3.68e-04 | 790 | 201 | 19 | int:TRRAP |
| Interaction | DPF3 interactions | 3.80e-04 | 95 | 201 | 6 | int:DPF3 | |
| Interaction | AR interactions | SMC1A RPS6KA1 PSMC1 PAGR1 ACTN2 BCL7A PTEN RBM25 PDS5A PLCG1 GNAS MED12 SKI CREB1 MED15 KAT7 EEF2 SNW1 SF3B1 INTS4 SMARCD1 SMARCD2 | 3.87e-04 | 992 | 201 | 22 | int:AR |
| Interaction | TEAD1 interactions | 3.97e-04 | 176 | 201 | 8 | int:TEAD1 | |
| Interaction | KALRN interactions | 4.02e-04 | 96 | 201 | 6 | int:KALRN | |
| Interaction | ABI1 interactions | 4.16e-04 | 223 | 201 | 9 | int:ABI1 | |
| Interaction | FOXB1 interactions | 4.17e-04 | 135 | 201 | 7 | int:FOXB1 | |
| Interaction | RBM25 interactions | TACO1 SRRM1 FYCO1 UPF3B RBM25 NKAP EEF2 SF3B1 MARK2 CTTN TRIM37 | 4.18e-04 | 323 | 201 | 11 | int:RBM25 |
| Interaction | EPB41L3 interactions | 4.20e-04 | 272 | 201 | 10 | int:EPB41L3 | |
| Interaction | SMC5 interactions | SRRM1 MYH9 SMC1A MCCC1 NDUFB10 RBM25 FBXO22 BRCA2 PDS5A TIMELESS EBNA1BP2 MAP7D3 NSMCE2 CREB1 CREM EEF2 SNW1 SF3B1 STEEP1 CTTN CDCA5 STAG2 | 4.32e-04 | 1000 | 201 | 22 | int:SMC5 |
| Interaction | NCF1 interactions | 4.49e-04 | 98 | 201 | 6 | int:NCF1 | |
| Interaction | VIM interactions | UBR1 MYH9 SPTAN1 KIF5B CUL1 MICAL1 MAP7D3 SH3GL1 UBR4 GRIA4 CNKSR2 CREB1 ARCN1 KIF7 KAT7 SNW1 SYVN1 CTTN TRIM37 | 4.57e-04 | 804 | 201 | 19 | int:VIM |
| Interaction | NFIX interactions | 4.73e-04 | 227 | 201 | 9 | int:NFIX | |
| Interaction | SHANK3 interactions | SLK RPS6KA1 RPS6KA2 SPTAN1 ACTN2 ITIH1 KIF5C KALRN KIF21A CNKSR2 KIF7 PPP3CB MACF1 CTTN | 4.78e-04 | 496 | 201 | 14 | int:SHANK3 |
| Interaction | DGCR2 interactions | 4.78e-04 | 181 | 201 | 8 | int:DGCR2 | |
| Interaction | FXR1 interactions | SMG1 MYH9 PDE9A FYCO1 UPF3B ACTN2 CDYL KAZN CUL1 KIF21A KIF7 EEF2 SNW1 DMRT2 ARHGEF2 CNOT1 TRIM37 | 4.80e-04 | 679 | 201 | 17 | int:FXR1 |
| Interaction | SMC1B interactions | 4.97e-04 | 16 | 201 | 3 | int:SMC1B | |
| GeneFamily | Mitogen-activated protein kinase-activated protein kinases | 1.09e-06 | 11 | 140 | 4 | 1156 | |
| GeneFamily | Myosin heavy chains | 4.40e-06 | 15 | 140 | 4 | 1098 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 2.75e-05 | 46 | 140 | 5 | 622 | |
| GeneFamily | PDZ domain containing | 1.83e-04 | 152 | 140 | 7 | 1220 | |
| GeneFamily | Ubiquitin protein ligase E3 component n-recognins | 1.22e-03 | 7 | 140 | 2 | 785 | |
| GeneFamily | Structural maintenance of chromosomes proteins|Cohesin complex | 1.22e-03 | 7 | 140 | 2 | 761 | |
| GeneFamily | Sorting nexins|PX-BAR domain containing | 1.43e-03 | 29 | 140 | 3 | 754 | |
| GeneFamily | Cohesin complex | 1.62e-03 | 8 | 140 | 2 | 1060 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.71e-03 | 66 | 140 | 4 | 722 | |
| GeneFamily | Sorting nexins|PX-BAR domain containing | 3.73e-03 | 12 | 140 | 2 | 1290 | |
| GeneFamily | Protein phosphatase catalytic subunits|EF-hand domain containing | 4.39e-03 | 13 | 140 | 2 | 693 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ZMYND11 SLK TRIO RPS6KA2 RPS6KA3 PTEN SNX13 RGL1 TLK1 BRCA2 RIN2 PDS5A CDYL MICAL3 KAZN KIF5C WWC1 CUL1 DUSP5 CREB1 DNAJC2 SNW1 PPP3CB MACF1 STAG2 TRIM37 | 3.40e-09 | 856 | 204 | 26 | M4500 |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | MYH9 TRIO SMC1A SPTAN1 TLK1 BRCA2 KIF5B SMC4 CEP250 ARHGEF2 CTTN | 4.97e-07 | 199 | 204 | 11 | M5893 |
| Coexpression | ONKEN_UVEAL_MELANOMA_UP | TRIO RPS6KA2 SPTAN1 MRPL19 SFI1 RBM25 UBXN4 MCM3AP DIAPH2 PDS5A GNAS MICAL1 INTS8 CREM DNAJC2 MED15 SNW1 CSPG4 MACF1 CTTN | 4.06e-06 | 790 | 204 | 20 | M12490 |
| Coexpression | GSE11961_FOLLICULAR_BCELL_VS_MEMORY_BCELL_DAY7_UP | MYH9 CYP26A1 ATP8B3 MICAL1 UBR4 MED15 SMARCD1 MARK2 ARHGEF2 CDCA5 | 4.08e-06 | 200 | 204 | 10 | M9338 |
| Coexpression | GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_4D_CULTURE_UP | 4.08e-06 | 200 | 204 | 10 | M387 | |
| Coexpression | GSE27786_CD4_TCELL_VS_NKTCELL_UP | 4.08e-06 | 200 | 204 | 10 | M4824 | |
| Coexpression | NUYTTEN_EZH2_TARGETS_DN | MYH9 MIS18BP1 TRAIP SYTL2 PAGR1 ALKBH5 NDUFB10 TLK1 BRCA2 TIMELESS DNAH2 TASP1 SMC4 GINS4 MAP7 USP37 NSMCE2 ARCN1 SNW1 PPP3CB CNOT1 CDCA5 TRIM37 | 5.35e-06 | 1023 | 204 | 23 | M17122 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | ZMYND11 SLK TRIO SNX13 TLK1 PDS5A CDYL MICAL3 KIF5C WWC1 CUL1 CREB1 PPP3CB TRIM37 | 1.89e-05 | 466 | 204 | 14 | M13522 |
| Coexpression | GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_UP | 2.87e-05 | 200 | 204 | 9 | M8497 | |
| Coexpression | YAGI_AML_WITH_T_8_21_TRANSLOCATION | SMG1 TRIO RPS6KA1 ACTN2 ITIH1 TIMELESS PLCG1 GNAS MED12 SMARCD1 MACF1 SMARCD2 | 3.81e-05 | 372 | 204 | 12 | M19261 |
| Coexpression | MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP | 7.35e-05 | 130 | 204 | 7 | M6590 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | ZMYND11 SMC1A PTEN NUP205 RBM25 UBXN4 PRAMEF11 PRAMEF6 SNW1 NEMF MARK2 CTTN SNX1 SNX5 | 9.83e-05 | 543 | 204 | 14 | MM997 |
| Coexpression | GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN | 1.23e-04 | 189 | 204 | 8 | M3112 | |
| Coexpression | FEVR_CTNNB1_TARGETS_DN | SRRM1 MIS18BP1 SMC1A TRAIP PTEN BRCA2 ETAA1 RPS6KA6 TIMELESS KIF5B CREB1 SF3B1 TRIM37 SNX5 | 1.23e-04 | 555 | 204 | 14 | M2343 |
| Coexpression | GSE21546_WT_VS_SAP1A_KO_DP_THYMOCYTES_DN | 1.42e-04 | 193 | 204 | 8 | M7544 | |
| Coexpression | GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_10DY_UP | 1.57e-04 | 196 | 204 | 8 | M41141 | |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_DN | 1.59e-04 | 250 | 204 | 9 | M11318 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | ZMYND11 SLK ATP6V0A1 MIS18BP1 HLF PTEN ALKBH5 RGL1 UBXN4 NEUROD1 KIF5B KIF5C GNAS KIF21A GRIA4 EEF2 SBDS STAG2 TRIM37 | 1.61e-04 | 946 | 204 | 19 | M39169 |
| Coexpression | GSE42021_TREG_PLN_VS_TREG_PRECURSORS_THYMUS_UP | 1.63e-04 | 197 | 204 | 8 | M9569 | |
| Coexpression | PILON_KLF1_TARGETS_UP | ABCA1 MIS18BP1 RNF168 TRIO RPS6KA3 ITIH1 TLK1 AMOTL1 ASCC2 WWC1 DEPTOR CTTN XPR1 | 1.70e-04 | 503 | 204 | 13 | M2226 |
| Coexpression | GSE22589_HEALTHY_VS_SIV_INFECTED_DC_UP | 1.75e-04 | 199 | 204 | 8 | M7798 | |
| Coexpression | GSE12198_CTRL_VS_LOW_IL2_STIM_NK_CELL_UP | 1.81e-04 | 200 | 204 | 8 | M7073 | |
| Coexpression | GSE41978_ID2_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN | 1.81e-04 | 200 | 204 | 8 | M9563 | |
| Coexpression | GSE19198_CTRL_VS_IL21_TREATED_TCELL_24H_DN | 1.81e-04 | 200 | 204 | 8 | M7231 | |
| Coexpression | GSE19923_HEB_KO_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_UP | 1.81e-04 | 200 | 204 | 8 | M7270 | |
| Coexpression | GSE18203_CTRL_VS_INTRATUMORAL_CPG_INJ_MC38_TUMOR_UP | 1.81e-04 | 200 | 204 | 8 | M7207 | |
| Coexpression | GSE17721_POLYIC_VS_CPG_1H_BMDC_UP | 1.81e-04 | 200 | 204 | 8 | M3934 | |
| Coexpression | GSE3039_NKT_CELL_VS_B2_BCELL_DN | 1.81e-04 | 200 | 204 | 8 | M6436 | |
| Coexpression | GSE8835_CD4_VS_CD8_TCELL_UP | 1.81e-04 | 200 | 204 | 8 | M6254 | |
| Coexpression | GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_UP | 1.81e-04 | 200 | 204 | 8 | M8968 | |
| Coexpression | JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP | MYH9 TRIO SYTL2 ADCY6 CABLES1 FBXO22 WWC1 MED15 MACF1 CTTN KIF1C | 2.16e-04 | 382 | 204 | 11 | M38972 |
| Coexpression | DITTMER_PTHLH_TARGETS_DN | 2.18e-04 | 70 | 204 | 5 | M18667 | |
| Coexpression | LINSLEY_MIR16_TARGETS | 2.21e-04 | 206 | 204 | 8 | M2284 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | MIS18BP1 RNF168 SMC1A RPS6KA3 DHX38 RBM25 BRCA2 ETAA1 RPS6KA6 PDS5A KIF5B SMC4 DNAJC2 SNW1 NEMF CNOT1 | 8.98e-06 | 469 | 198 | 16 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | SPTAN1 DHX38 RBM25 BRCA2 ETAA1 RPS6KA6 PDS5A MICAL3 KIF21A SMC4 MAP7 USP37 DNAJC2 PALS1 SNW1 NEMF CNOT1 | 1.10e-05 | 532 | 198 | 17 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | DevelopingKidney_e15.5_ureter tip_flank cortic collct_emap-27752_k-means-cluster#5_top-relative-expression-ranked_1000 | SMG1 MYH9 RNF168 TRIO MRPL19 PTEN SNX13 TLK1 UBXN4 KIF5C WWC1 INTS8 ERCC6L2 | 1.90e-05 | 339 | 198 | 13 | gudmap_developingKidney_e15.5_ureter tip_flank cortic collct_1000_k5 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#4 | UBR1 SRRM1 SLK RNF168 SMC1A RPS6KA6 KIF5C KIF21A STXBP6 MACF1 | 2.18e-05 | 203 | 198 | 10 | Facebase_RNAseq_e9.5_Mandibular Arch_1000_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | RNF168 PDE9A SMC1A UPF3B BRCA2 RPS6KA6 PDS5A KIF5C SMC4 SBDS NEMF XPR1 | 3.76e-05 | 311 | 198 | 12 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | ATP6V0A1 MIS18BP1 RNF168 PDE9A SMC1A MRTFB BRCA2 RPS6KA6 MICAL3 KIF5C NKAP MICAL1 KIF21A SMC4 KIF7 CBY2 CEP250 ERCC6L2 MACF1 CTTN | 4.40e-05 | 780 | 198 | 20 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | RNF168 SMC1A BRCA2 RPS6KA6 PDS5A KIF5C WWC1 MAP7D3 WNT7B KIF21A SMC4 MAP7 DNAJC2 NEMF HES5 | 7.15e-05 | 498 | 198 | 15 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 8.28e-05 | 192 | 198 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3 | |
| CoexpressionAtlas | CD positive, CD4 Test DB, 4+8-B220-, Spleen, avg-1 | TRIO SYTL2 PLCG1 DNAH8 GALNT10 TASP1 SMC4 SKI IFIT1 BICDL1 PPP3CC MACF1 | 8.36e-05 | 338 | 198 | 12 | GSM403987_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | RNF168 PDE9A SMC1A UPF3B MRTFB BRCA2 PDS5A MICAL3 KIF5C NKAP WNT7B KIF21A SMC4 DNAJC2 SBDS CEP250 NEMF ERCC6L2 CTTN XPR1 | 1.05e-04 | 831 | 198 | 20 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | alpha beta T cells, T.4.LN.BDC, 4+ 8- BDC+, Lymph Node, avg-3 | TRIO SYTL2 ADCY6 PLCG1 DNAH8 TET3 GALNT10 SKI IFIT1 BICDL1 PPP3CC MARK2 | 1.29e-04 | 354 | 198 | 12 | GSM605753_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | RNF168 PDE9A SMC1A UPF3B ACTN2 BRCA2 RPS6KA6 PDS5A MICAL3 KIF5C WWC1 MAP7D3 WNT7B KIF21A SMC4 MAP7 DNAJC2 SBDS CBY2 NEMF HES5 XPR1 | 1.46e-04 | 989 | 198 | 22 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | SLK MIS18BP1 RNF168 SMC1A HLF SFI1 ACTN2 GPR179 BRCA2 MCM3AP RPS6KA6 CDYL KIF5C GALNT10 KIF21A SMC4 MAP7 PDCD7 KIF7 SBDS MACF1 ARHGEF2 | 1.46e-04 | 989 | 198 | 22 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | CD positive, CD4 Test JS, 4+8-B220-, Spleen, avg-3 | TRIO SYTL2 PLCG1 DNAH8 TET3 GALNT10 SMC4 SKI IFIT1 BICDL1 PPP3CC MARK2 | 1.47e-04 | 359 | 198 | 12 | GSM404000_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | SMG1 SRRM1 SLK RNF168 TRIO SMC1A KIF5C CCL25 WNT7B KIF21A PDCD7 STXBP6 SBDS MACF1 STAG2 TRIM37 | 1.53e-04 | 595 | 198 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500 | MIS18BP1 RNF168 PDE9A SMC1A ACTN2 BRCA2 RPS6KA6 MICAL3 KIF5C CCDC33 KIF21A SMC4 KIF7 MACF1 | 2.25e-04 | 492 | 198 | 14 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | UBR1 SRRM1 SLK RNF168 PDE9A SMC1A BRCA2 RPS6KA6 KIF5C CCL25 KIF21A DNAH2 SMC4 STXBP6 SBDS MACF1 | 2.86e-04 | 629 | 198 | 16 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | MYH3 SYNPO2 RPS6KA3 TIAM2 CABLES1 TLK1 AMOTL1 RPS6KA6 KIF5C COL19A1 KIF21A USP37 CREB1 SF3B1 PPP3CB DMRT2 ERCC6L2 TRIM37 SNX5 | 3.23e-04 | 836 | 198 | 19 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 |
| CoexpressionAtlas | alpha beta T cells, T.4Nve.LN, 4+ 8- 25- 62Lhi 44lo, Lymph Node, avg-3 | SYTL2 ADCY6 PLCG1 DNAH8 GALNT10 TASP1 SKI IFIT1 BICDL1 PPP3CC MARK2 | 3.31e-04 | 336 | 198 | 11 | GSM538374_500 |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-07 | 188 | 205 | 9 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 2.45e-07 | 189 | 205 | 9 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EECs|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.01e-06 | 165 | 205 | 8 | 4b4e75ad0eb0a6b00c30a000ec6267e23ba2e496 | |
| ToppCell | Control-CD8+_T_activated|Control / Disease group and Cell class | 2.28e-06 | 184 | 205 | 8 | b86cc48b744b3206880ec1373fe6068e14bf9680 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 2.68e-06 | 188 | 205 | 8 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.78e-06 | 189 | 205 | 8 | 3b48b0d220cc24d5170713d61fa91f5bb6c21841 | |
| ToppCell | COVID-19-kidney-CNT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.13e-06 | 192 | 205 | 8 | 760c6b9628de9693034b00c5025c5c4df94bb2e8 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 3.25e-06 | 193 | 205 | 8 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.25e-06 | 193 | 205 | 8 | e74fdc8718fe0933e1f4dd3fe37e2134983b99b6 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.25e-06 | 193 | 205 | 8 | 658c2b30a4d806c5ce78ea4392fe8eb86b8d1e99 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 3.38e-06 | 194 | 205 | 8 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 3.38e-06 | 194 | 205 | 8 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 3.60e-06 | 138 | 205 | 7 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.78e-06 | 197 | 205 | 8 | 71367bebc23d0e81f60f780d6b0ab3a1783ac014 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 3.78e-06 | 197 | 205 | 8 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | 356C-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.78e-06 | 197 | 205 | 8 | 0f9836554ace3f9d155ebafdd719aa26466ca44e | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.93e-06 | 198 | 205 | 8 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 3.93e-06 | 198 | 205 | 8 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.93e-06 | 198 | 205 | 8 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Mesoderm|6m / Sample Type, Dataset, Time_group, and Cell type. | 4.23e-06 | 200 | 205 | 8 | 0f6851baf0cf2a8b0c95a7a585c4407c330c5f6c | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT-L2/3_IT_VISp_Adamts2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.07e-06 | 156 | 205 | 7 | 2cd007b423c2395c5ce331902e7f27c805755eb3 | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.41e-06 | 157 | 205 | 7 | 6730b775308f45a2f3946016bdbb7f8e5b5efe49 | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 1.77e-05 | 176 | 205 | 7 | 36f77d878a53b30465b0dea8333a3865dba75613 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-05 | 180 | 205 | 7 | 78fdcfb3fdbf36469cae78407cda5bd0996930d8 | |
| ToppCell | normal_Lung-Myeloid_cells-CD207+CD1a+_LCs|normal_Lung / Location, Cell class and cell subclass | 2.12e-05 | 181 | 205 | 7 | b55dbcfae8c92d322071906831489830a22239b9 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_9|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.17e-05 | 122 | 205 | 6 | 489a01c71882be5a6d71a19d06574698988c20f6 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_9|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.17e-05 | 122 | 205 | 6 | 7dabf8b4c34a3714f45c3a99c1aa159e2d0b7e9c | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 2.27e-05 | 183 | 205 | 7 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-05 | 184 | 205 | 7 | f4344f3c407b2d4d703fe56e43d84dbfe60ba833 | |
| ToppCell | PBMC-Mild-cDC_9|Mild / Compartment, Disease Groups and Clusters | 2.35e-05 | 184 | 205 | 7 | 2e0c9a2c40c892a2d435eafb31f1f838de9baf15 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Nr2f2_Necab1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.38e-05 | 124 | 205 | 6 | 298ff8bd8f0459f44ce8a8aea889c6f1cf84ac5f | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-05 | 187 | 205 | 7 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | COPD-Stromal-Pericyte|Stromal / Disease state, Lineage and Cell class | 2.61e-05 | 187 | 205 | 7 | 406ecd1dabb3ed8d871aef159f7bd1e383434953 | |
| ToppCell | COVID-19-kidney|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.61e-05 | 187 | 205 | 7 | d23aae9419d460b78b1d4092d7acd9108a47cfbe | |
| ToppCell | COVID-19-kidney-DCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.70e-05 | 188 | 205 | 7 | 1d56cd409793f05cca20757ab26e91f1a1ee67b5 | |
| ToppCell | Int-URO-Lymphocyte-T_NK-T_NK_proliferative|Int-URO / Disease, Lineage and Cell Type | 2.89e-05 | 190 | 205 | 7 | 005967c540418b85311308072a07c684f4296aef | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.89e-05 | 190 | 205 | 7 | 6ea9fa08bd97bedcb21d3654467e7f8dd74c8fd0 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.89e-05 | 190 | 205 | 7 | d594da827e3c16644952b9589cc12b947ce36279 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.89e-05 | 190 | 205 | 7 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.89e-05 | 190 | 205 | 7 | 49e09cdb843b3d889a06a811aa5affae68b25a75 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.99e-05 | 191 | 205 | 7 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.99e-05 | 191 | 205 | 7 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 2.99e-05 | 191 | 205 | 7 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 3.09e-05 | 192 | 205 | 7 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.09e-05 | 192 | 205 | 7 | 5c7e8b80b44d9ce55c797cdf8267ac5382e26cac | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.19e-05 | 193 | 205 | 7 | d1445b8bf2bab36e1a326ddb2a528151db016c7d | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.19e-05 | 193 | 205 | 7 | 3ed46f5a7419ec4eddbd0df0d9b5f53aa486198b | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-skeletal_muscle_satellite_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.19e-05 | 193 | 205 | 7 | 1aa3ab528605dc7b2fec46e759c9d1ee93d59b11 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.30e-05 | 194 | 205 | 7 | 46070fbb0ee0eb9e1801c43b73a15707471056dc | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.30e-05 | 194 | 205 | 7 | abacb6a8d7a9003f2f6c2be0305507f1c1c50347 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.30e-05 | 194 | 205 | 7 | 7002937e8903e037332a215d00fbc7c7843b33f2 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Differentiated-like-AC-like-AC-like-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.30e-05 | 194 | 205 | 7 | 8b81f039f5b25d35a4d5a41b27d4d9360ba22f15 | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-Teffector/EM_CD4|blood / Manually curated celltypes from each tissue | 3.30e-05 | 194 | 205 | 7 | 8499c03fa3d5cf9631b128681b13b7fc512b7e63 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 3.41e-05 | 195 | 205 | 7 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-05 | 195 | 205 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-05 | 195 | 205 | 7 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.52e-05 | 196 | 205 | 7 | e0447ad2efb021b63c7fef000d39b6b21fbe6113 | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_macrophage-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.52e-05 | 196 | 205 | 7 | 3bca88eede3dd7368715ced02e3bacd1e3e82cab | |
| ToppCell | COVID-19-Heart-Mito_CM|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.64e-05 | 197 | 205 | 7 | 44e49943d62bfe622b40ad0460093d31540544df | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.64e-05 | 197 | 205 | 7 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.64e-05 | 197 | 205 | 7 | 5c4cee914baf7cb43e9cb99cc9e3ae823856dc15 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-IPC_like|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 3.75e-05 | 198 | 205 | 7 | 6d12ecaa9532c134d9c4562534dcb59a6420b4d3 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.75e-05 | 198 | 205 | 7 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-IPC_like-IPs_and_early_cortical_neurons|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 3.75e-05 | 198 | 205 | 7 | 7943e4f67c3d6efb5c8b00aa0ff3cfe7be10c48d | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Proliferating-cycling_dorsal_progenitors|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 3.75e-05 | 198 | 205 | 7 | dada1c19a261c8e1090957cd7e37f2a43a9fe14f | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_macrophage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.88e-05 | 199 | 205 | 7 | 980b10b81ee9dc952e3be25bd294201ce5a4ca8b | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.88e-05 | 199 | 205 | 7 | 15f7814b7074170eee7ccacaa670b1d128fc68bb | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_macrophage-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.88e-05 | 199 | 205 | 7 | cbd423c31d75f6d2f5ae85d2241641fcbe630b81 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Radial_glial-RGCs_3|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 3.88e-05 | 199 | 205 | 7 | 79d87e2b0adeff2d33c3b699afe7211fddc4f285 | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 3.88e-05 | 199 | 205 | 7 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.88e-05 | 199 | 205 | 7 | b1753474152b82a0b811b9878c890a359e14919a | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Stem_cells|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 4.00e-05 | 200 | 205 | 7 | 31dd81df9aa754a1e69b905bf9b8ce73ff8175aa | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.00e-05 | 200 | 205 | 7 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.00e-05 | 200 | 205 | 7 | a66449b22b39dd6987fc2c3ed160d24564234ced | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuroepithelial|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 4.00e-05 | 200 | 205 | 7 | 25f4c051c2e869481f33c22ad54de97efac444ad | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.00e-05 | 200 | 205 | 7 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Stem_cells-Neuroepithelial_cell|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 4.00e-05 | 200 | 205 | 7 | 54174a485a82480726fa06efa6e050ddea77cb3c | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2|World / Primary Cells by Cluster | 4.00e-05 | 200 | 205 | 7 | 4923d7a4f00853c4d76fc1cc0fa82d522a2302e7 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_4(SST)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 4.00e-05 | 200 | 205 | 7 | 347a510755374c6a66acee326565dfc447993f18 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m-Mesenchymal-Mesoderm|3m / Sample Type, Dataset, Time_group, and Cell type. | 4.00e-05 | 200 | 205 | 7 | 538ae964db58c4acafe93f735b3e03fc08fdaac6 | |
| ToppCell | Non-neuronal-Dividing-IPC-IPC-div2-5|World / Primary Cells by Cluster | 4.00e-05 | 200 | 205 | 7 | dc1c1506823eaa105f1532c6b5d4efa14e788314 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 4.00e-05 | 200 | 205 | 7 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | mild-CD163+_Monocytes_(Sample_ID1_d7)|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.00e-05 | 200 | 205 | 7 | 82126e25bfd8fba78dc1348fa5ad6a576289a139 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuroepithelial-Proteoglycan-expressing_cell|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 4.00e-05 | 200 | 205 | 7 | da45a85a4667965b24ba824af871157af5b4cd19 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.27e-05 | 155 | 205 | 6 | 8b524c65fa5c901f70c7caae4ec7fd2859eaf227 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_low-phase|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.27e-05 | 155 | 205 | 6 | 7fe8b8c0c8a9e3190cfd52d3934509e6780e1717 | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 9.84e-05 | 160 | 205 | 6 | f843287ed57d2d5a3b3f6dfb03b6934e330e6645 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Pdlim5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.02e-04 | 161 | 205 | 6 | bf70be1de418615b5442ec684552551edaf1f072 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L2/3_IT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.02e-04 | 161 | 205 | 6 | e3327c296d48e821004e61a573abb75624a6f040 | |
| ToppCell | Globus_pallidus-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.02e-04 | 161 | 205 | 6 | ebcd5066e82b7760b9da6adc02d11258d1309dab | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.13e-04 | 164 | 205 | 6 | e5258efd6765acfc394708f697ec76acaef09079 | |
| ToppCell | Healthy_donor-HSPC|World / disease group, cell group and cell class (v2) | 1.24e-04 | 167 | 205 | 6 | 70630ebdfee8171d625811844f8a7c94736d101e | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_progenitors-Progenitor|lymph-node_spleen / Manually curated celltypes from each tissue | 1.24e-04 | 167 | 205 | 6 | cb396f3edb9e8fdc316091e8e193dbba50e0be0c | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.29e-04 | 168 | 205 | 6 | e979a4fbeb9f21048b47d69e6da75c57650697f2 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.33e-04 | 169 | 205 | 6 | 20fbf78382fb0ba9a63ab1aa0abc615476994ac5 | |
| ToppCell | COVID-19_Mild-PLT_2|World / Disease Group and Platelet Clusters | 1.33e-04 | 169 | 205 | 6 | 6abfdc8b437f19c03b408bedc245059d28c6ba6a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT2_L6_FEZF2-Exc_L6_FEZF2_SLITRK6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.33e-04 | 169 | 205 | 6 | 1c9e54e7b14eb99996590fb93b257cf881a9f184 | |
| ToppCell | 3'_v3-bone_marrow-Mast-Mast_cell_lympho|bone_marrow / Manually curated celltypes from each tissue | 1.37e-04 | 170 | 205 | 6 | 4dedf482cd4521b3f87d2b5ae80f7a3ea8686a15 | |
| ToppCell | COVID-19_Mild-PLT_2|COVID-19_Mild / Disease Group and Platelet Clusters | 1.51e-04 | 173 | 205 | 6 | d11705e56b6b21eec963ea224717f27680c781ed | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-04 | 173 | 205 | 6 | 2b448acd5e584f24567204c31b8d74715e92f32a | |
| Drug | Rifampicin [13292-46-1]; Down 200; 4.8uM; MCF7; HT_HG-U133A | SMC1A RPS6KA2 TRAIP CYP26A1 TIMELESS PLCG1 IQCE MICAL1 WNT7B MED15 STXBP6 SMARCD1 TOP3A | 2.32e-08 | 194 | 204 | 13 | 4126_DN |
| Drug | Boldine [476-70-0]; Up 200; 12.2uM; HL60; HT_HG-U133A | ATP6V0A1 SMC1A SPTAN1 HOXA10 MRTFB ETAA1 DIAPH2 KIF5C UBR4 MAP7 CCDC57 CREM CFAP44 | 3.33e-08 | 200 | 204 | 13 | 2148_UP |
| Drug | Nilutamide [63612-50-0]; Up 200; 12.6uM; MCF7; HT_HG-U133A | TRIO SMC1A RPS6KA1 RPS6KA2 SFI1 BCL7A ASCC2 TAFAZZIN CEP250 SMARCD1 MARK2 KIF1C | 1.95e-07 | 194 | 204 | 12 | 5362_UP |
| Drug | DEAC | 5.90e-07 | 55 | 204 | 7 | CID000007277 | |
| Drug | Flumequine [42835-25-6]; Down 200; 15.4uM; PC3; HT_HG-U133A | SMC1A SNX13 KAZN PLCG1 TAFAZZIN DEPTOR MAP7 CREM FCF1 CEP250 TOP3A | 1.50e-06 | 194 | 204 | 11 | 5104_DN |
| Drug | Lansoprazole [103577-45-3]; Up 200; 10.8uM; HL60; HT_HG-U133A | SFI1 BRCA2 ETAA1 PLCG1 KIF5C LTB4R WWC1 GALNT10 DEPTOR CREM FCF1 | 1.75e-06 | 197 | 204 | 11 | 2967_UP |
| Drug | Pirlindole mesylate [60762-57-4]; Up 200; 12.4uM; HL60; HT_HG-U133A | MYH2 SFI1 HOXA10 MCM3AP CFAP45 RPS6KA6 CACNA1G PLCG1 IFIT1 CSPG4 KIF1C | 1.84e-06 | 198 | 204 | 11 | 3140_UP |
| Drug | Methapyrilene hydrochloride [135-23-9]; Up 200; 13.4uM; MCF7; HT_HG-U133A | RPS6KA2 TRAIP COLGALT2 ADCY6 GNAS TRMT9B DNAH2 CNKSR2 CCDC57 IFIT1 ADGRD2 | 1.93e-06 | 199 | 204 | 11 | 4990_UP |
| Drug | BI D1870 | 1.97e-06 | 11 | 204 | 4 | ctd:C516541 | |
| Drug | carbachol | MYH2 MYH3 MYH9 MYH11 RPS6KA1 RPS6KA2 RPS6KA3 PTEN ADCY6 RPS6KA6 CACNA1G TIMELESS PLCG1 GNAS HTR1A TASP1 CREB1 MARK2 MAPK4 TRIM37 | 4.14e-06 | 688 | 204 | 20 | CID000002551 |
| Drug | Ovta | 5.84e-06 | 14 | 204 | 4 | CID003081047 | |
| Drug | AD 288 | 5.84e-06 | 14 | 204 | 4 | CID000073553 | |
| Drug | Nitrendipine [39562-70-4]; Up 200; 11uM; HL60; HT_HG-U133A | NEUROD1 RIN2 SCN5A CACNA1G KIF5C TAFAZZIN CCDC57 CREM SLC8A1 CTTN | 9.62e-06 | 192 | 204 | 10 | 3087_UP |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; HL60; HT_HG-U133A | SMC1A HOXA10 MCM3AP CACNA1G PLCG1 UBR4 MAP7 CCDC57 CREM CEP250 | 1.01e-05 | 193 | 204 | 10 | 2682_UP |
| Drug | R165481 | 1.05e-05 | 16 | 204 | 4 | CID005459348 | |
| Drug | H-89, Dihydrochloride; Up 200; 0.5uM; MCF7; HT_HG-U133A | ATP6V0A1 RPS6KA1 RPS6KA2 TRAIP KIF5C MICAL1 SMC4 PPP3CC STEEP1 SMARCD3 | 1.05e-05 | 194 | 204 | 10 | 6878_UP |
| Drug | Debrisoquin sulfate [581-88-4]; Up 200; 9uM; MCF7; HT_HG-U133A | ATP6V0A1 TRAIP SPTAN1 BCL7A ETAA1 MICAL3 SKI STXBP6 MARK2 STAG2 | 1.15e-05 | 196 | 204 | 10 | 5288_UP |
| Drug | Lovastatin [75330-75-5]; Up 200; 9.8uM; HL60; HT_HG-U133A | SNX13 MCM3AP CFAP45 CACNA1G HTR1A MAP7 CREM BICDL1 KLHL25 CTTN | 1.15e-05 | 196 | 204 | 10 | 2494_UP |
| Drug | NS-398; Down 200; 10uM; MCF7; HT_HG-U133A | CYP26A1 SFI1 RIN2 KAZN PLCG1 MICAL1 SPAG7 KLHL25 STEEP1 TOP3A | 1.20e-05 | 197 | 204 | 10 | 6897_DN |
| Drug | estradiol, USP; Up 200; 0.01uM; HL60; HT_HG-U133A | 1.26e-05 | 198 | 204 | 10 | 2701_UP | |
| Drug | PHA-00767505E [723337-45-9]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.26e-05 | 198 | 204 | 10 | 6596_UP | |
| Drug | Meptazinol hydrochloride [59263-76-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A | CYP26A1 SYTL2 CDYL PLCG1 MED12 TAFAZZIN IQCE PPP3CC SMARCD1 TOP3A | 1.31e-05 | 199 | 204 | 10 | 7326_DN |
| Drug | Carbenoxolone disodium salt [7421-40-1]; Down 200; 6.6uM; HL60; HT_HG-U133A | SPTAN1 SFI1 SCN5A CFAP45 GNAS CCDC33 TRMT9B ADGRD2 MARK2 MYBPC1 | 1.37e-05 | 200 | 204 | 10 | 3014_DN |
| Drug | Carbachol [51-83-2]; Down 200; 21.8uM; MCF7; HT_HG-U133A | SMC1A RPS6KA1 SFI1 TLK1 RIN2 CDYL TIMELESS KIF5C LTB4R KIF1C | 1.37e-05 | 200 | 204 | 10 | 3380_DN |
| Drug | ICI182,780; Up 200; 1uM; MCF7; HT_HG-U133A | CYP26A1 SFI1 CFAP45 DIAPH2 IQCE OPRM1 KLHL25 CEP250 MAPK4 CFAP44 | 1.37e-05 | 200 | 204 | 10 | 7534_UP |
| Drug | bromfenacoum | MYH9 MYH11 ATP6V0A1 SPTAN1 GCLC PDS5A KAZN PLCG1 KIF5C CUL1 KIF21A GRIA4 EEF2 IARS2 SF3B1 MCU MACF1 CTTN | 2.16e-05 | 644 | 204 | 18 | ctd:C013418 |
| Drug | Methapyrilene hydrochloride [135-23-9]; Down 200; 13.4uM; PC3; HT_HG-U133A | 5.90e-05 | 191 | 204 | 9 | 6644_DN | |
| Drug | Mycophenolic acid [24280-93-1]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 5.90e-05 | 191 | 204 | 9 | 2857_DN | |
| Drug | 5707885; Down 200; 50uM; PC3; HT_HG-U133A | 6.14e-05 | 192 | 204 | 9 | 6438_DN | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; PC3; HG-U133A | 6.14e-05 | 192 | 204 | 9 | 458_DN | |
| Drug | N6-methyladenosine [1867-73-8]; Up 200; 14.2uM; PC3; HT_HG-U133A | 6.39e-05 | 193 | 204 | 9 | 6732_UP | |
| Drug | Glycocholic acid [475-31-0]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 6.65e-05 | 194 | 204 | 9 | 5316_DN | |
| Drug | Cinchonine [118-10-5]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 6.65e-05 | 194 | 204 | 9 | 4107_DN | |
| Drug | Meclozine dihydrochloride [1104-22-9]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 6.65e-05 | 194 | 204 | 9 | 3285_UP | |
| Drug | Ethamsylate [2624-44-4]; Up 200; 15.2uM; PC3; HT_HG-U133A | 6.92e-05 | 195 | 204 | 9 | 4576_UP | |
| Drug | Ethisterone [434-03-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A | ATP6V0A1 TRIO SPTAN1 SNX13 MCM3AP KIF5B PLCG1 MAP7D3 SMARCD1 | 6.92e-05 | 195 | 204 | 9 | 3864_DN |
| Drug | Flunisolide [3385-03-3]; Up 200; 9.2uM; MCF7; HT_HG-U133A | COLGALT2 HOXA10 NEUROD1 MCM3AP CACNA1G TRMT9B KALRN GRIA4 USH1C | 7.20e-05 | 196 | 204 | 9 | 3923_UP |
| Drug | Ethaverine hydrochloride [985-13-7]; Up 200; 9.2uM; MCF7; HT_HG-U133A | PDE9A RPS6KA2 CYP26A1 ADCY6 CFAP45 LTB4R COL19A1 IFIT1 KLHL25 | 7.20e-05 | 196 | 204 | 9 | 3375_UP |
| Drug | Ciprofloxacin hydrochloride [93107-08-5]; Down 200; 10.8uM; PC3; HG-U133A | 7.20e-05 | 196 | 204 | 9 | 1939_DN | |
| Drug | Ethotoin [86-35-1]; Down 200; 19.6uM; MCF7; HT_HG-U133A | 7.20e-05 | 196 | 204 | 9 | 3892_DN | |
| Drug | Memantine Hydrochloride [41100-52-1]; Down 200; 18.6uM; MCF7; HT_HG-U133A | 7.49e-05 | 197 | 204 | 9 | 4135_DN | |
| Drug | Carcinine [56897-53-1]; Up 200; 22uM; MCF7; HT_HG-U133A | 7.49e-05 | 197 | 204 | 9 | 3242_UP | |
| Drug | Rapamycin; Down 200; 0.1uM; HL60; HT_HG-U133A | 7.49e-05 | 197 | 204 | 9 | 2702_DN | |
| Drug | Harmaline hydrochloride dihydrate [6027-98-1]; Down 200; 14uM; PC3; HT_HG-U133A | 7.49e-05 | 197 | 204 | 9 | 6623_DN | |
| Drug | Clemizole hydrochloride [1163-36-6]; Down 200; 11uM; MCF7; HT_HG-U133A | 7.49e-05 | 197 | 204 | 9 | 2301_DN | |
| Drug | Rapamycin; Up 200; 0.1uM; HL60; HT_HG-U133A | 7.49e-05 | 197 | 204 | 9 | 6180_UP | |
| Drug | Etidronic acid, disodium salt [7414-83-7]; Down 200; 16uM; HL60; HT_HG-U133A | 7.49e-05 | 197 | 204 | 9 | 2985_DN | |
| Drug | Tranylcypromine hydrochloride [1986-47-6]; Down 200; 23.6uM; PC3; HT_HG-U133A | 7.49e-05 | 197 | 204 | 9 | 7293_DN | |
| Drug | rofecoxib; Down 200; 10uM; MCF7; HG-U133A | 7.78e-05 | 198 | 204 | 9 | 166_DN | |
| Drug | Meclofenamic acid sodium salt monohydrate [6385-02-0]; Up 200; 11.8uM; PC3; HT_HG-U133A | 7.78e-05 | 198 | 204 | 9 | 7280_UP | |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 7.78e-05 | 198 | 204 | 9 | 3405_UP | |
| Drug | Dehydrocholic acid [81-23-2]; Down 200; 9.6uM; MCF7; HT_HG-U133A | SLK ATP6V0A1 RPS6KA2 CYP26A1 CDYL TIMELESS STEEP1 SMARCD1 CFAP44 | 7.78e-05 | 198 | 204 | 9 | 5681_DN |
| Drug | Butacaine [149-16-6]; Up 200; 13uM; MCF7; HT_HG-U133A | 7.78e-05 | 198 | 204 | 9 | 3469_UP | |
| Drug | Adrenosterone [382-45-6]; Up 200; 13.4uM; HL60; HT_HG-U133A | 7.78e-05 | 198 | 204 | 9 | 3107_UP | |
| Drug | Ethamivan [304-84-7]; Down 200; 18uM; MCF7; HT_HG-U133A | ATP6V0A1 SPTAN1 ETAA1 TAFAZZIN IQCE WNT7B SMC4 CLASRP STXBP6 | 7.78e-05 | 198 | 204 | 9 | 2879_DN |
| Drug | Dimenhydrinate [523-87-5]; Up 200; 8.6uM; HL60; HT_HG-U133A | 7.78e-05 | 198 | 204 | 9 | 2400_UP | |
| Drug | Melatonin [73-31-4]; Up 200; 17.2uM; MCF7; HT_HG-U133A | 7.78e-05 | 198 | 204 | 9 | 5393_UP | |
| Drug | Monensin sodium salt [22373-78-0]; Down 200; 5.8uM; HL60; HT_HG-U133A | 7.78e-05 | 198 | 204 | 9 | 2580_DN | |
| Drug | Nafcillin sodium salt monohydrate [7177-50-6]; Up 200; 8.8uM; MCF7; HT_HG-U133A | ACTN2 RPS6KA6 CACNA1G TAFAZZIN COL19A1 CCDC57 KLHL25 ARHGEF2 KIF1C | 7.78e-05 | 198 | 204 | 9 | 4103_UP |
| Drug | Epicatechin-(-) [154-23-4]; Up 200; 13.8uM; PC3; HT_HG-U133A | 7.78e-05 | 198 | 204 | 9 | 4594_UP | |
| Drug | rosiglitazone; Up 200; 10uM; HL60; HT_HG-U133A | 7.78e-05 | 198 | 204 | 9 | 2693_UP | |
| Drug | (R)-Propranolol hydrochloride [13071-11-9]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 7.78e-05 | 198 | 204 | 9 | 3553_DN | |
| Drug | H-89, Dihydrochloride; Down 200; 0.5uM; MCF7; HT_HG-U133A | SPTAN1 CYP26A1 SFI1 TIMELESS DEPTOR SPAG7 CREB1 IFIT1 CFAP44 | 7.78e-05 | 198 | 204 | 9 | 6878_DN |
| Drug | ICI 182,780; Up 200; 1uM; MCF7; HT_HG-U133A | 7.78e-05 | 198 | 204 | 9 | 6965_UP | |
| Drug | ncga | 7.99e-05 | 2 | 204 | 2 | CID003035664 | |
| Drug | Milrinone [78415-72-2]; Down 200; 19uM; PC3; HT_HG-U133A | 8.09e-05 | 199 | 204 | 9 | 5856_DN | |
| Drug | Folinic acid calcium salt [6035-45-6]; Down 200; 7.8uM; MCF7; HT_HG-U133A | TRIO RPS6KA1 CYP26A1 NEUROD1 KIF5C TAFAZZIN MICAL1 SKI KLHL25 | 8.09e-05 | 199 | 204 | 9 | 4725_DN |
| Drug | Cefuroxime sodium salt [56238-63-2]; Down 200; 9uM; PC3; HT_HG-U133A | 8.09e-05 | 199 | 204 | 9 | 5787_DN | |
| Drug | Meptazinol hydrochloride [59263-76-2]; Down 200; 14.8uM; HL60; HT_HG-U133A | 8.09e-05 | 199 | 204 | 9 | 2906_DN | |
| Drug | nordihydroguaiaretic acid; Up 200; 1uM; HL60; HT_HG-U133A | 8.09e-05 | 199 | 204 | 9 | 6182_UP | |
| Drug | Althiazide [5588-16-9]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 8.41e-05 | 200 | 204 | 9 | 6829_DN | |
| Drug | K00085 | 9.34e-05 | 27 | 204 | 4 | CID009549283 | |
| Drug | AC1MS9WM | 9.34e-05 | 27 | 204 | 4 | CID003530978 | |
| Drug | AC1L1OB7 | 1.11e-04 | 11 | 204 | 3 | CID000007235 | |
| Drug | Antigens, Polyomavirus Transforming | MYH9 MIS18BP1 RNF168 SMC1A RPS6KA3 PTEN NUP205 TIMELESS NKAP DUSP5 SMC4 SPAG7 IFIT1 EEF2 CTTN STAG2 XPR1 | 1.16e-04 | 668 | 204 | 17 | ctd:D000952 |
| Drug | Hc1 | 1.25e-04 | 29 | 204 | 4 | CID011963785 | |
| Drug | Cocaine | SYNPO2 MYH9 SLK RPS6KA1 SPTAN1 RPS6KA3 CYP26A1 ACTN2 PTEN TIAM2 PLCG1 DNAH8 RPL36 HTR1A KALRN SH3GL1 UBR4 XBP1 GRIA4 CNKSR2 PDCD7 CREB1 CREM OPRM1 PALS1 HCRTR2 | 1.27e-04 | 1314 | 204 | 26 | ctd:D003042 |
| Drug | 2-ketoarginine | 1.47e-04 | 12 | 204 | 3 | CID000000558 | |
| Drug | Cymal-6 | 1.90e-04 | 13 | 204 | 3 | CID000447688 | |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; PC3; HT_HG-U133A | 2.02e-04 | 177 | 204 | 8 | 4652_DN | |
| Drug | Guanosine Triphosphate | 2.09e-04 | 33 | 204 | 4 | ctd:D006160 | |
| Drug | A61603 | 2.09e-04 | 33 | 204 | 4 | CID004038180 | |
| Drug | N-ethylmaleimide | MYH2 MYH3 MYH9 MYH11 SPTAN1 ADCY6 KIF5B HTR1A KIF21A GRIA4 KIF7 OPRM1 SNX1 KIF1C | 2.22e-04 | 511 | 204 | 14 | CID000004362 |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.27e-04 | 180 | 204 | 8 | 4821_DN | |
| Drug | 2-hydroxysebacate | 2.38e-04 | 3 | 204 | 2 | CID000128458 | |
| Drug | Harmine hydrochloride [343-27-1]; Down 200; 16uM; MCF7; HT_HG-U133A | 2.54e-04 | 183 | 204 | 8 | 2750_DN | |
| Drug | Hexetidine [141-94-6]; Up 200; 11.8uM; HL60; HT_HG-U133A | 2.73e-04 | 185 | 204 | 8 | 2457_UP | |
| Drug | lomustine; Up 200; 100uM; MCF7; HT_HG-U133A | 2.73e-04 | 185 | 204 | 8 | 7089_UP | |
| Drug | clenbuterol | 3.00e-04 | 142 | 204 | 7 | CID000002783 | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A | 3.05e-04 | 188 | 204 | 8 | 5882_UP | |
| Drug | Ketanserin tartrate hydrate [83846-83-7]; Down 200; 7uM; PC3; HT_HG-U133A | 3.16e-04 | 189 | 204 | 8 | 6649_DN | |
| Drug | genistein; Up 200; 10uM; HL60; HT_HG-U133A | 3.16e-04 | 189 | 204 | 8 | 2695_UP | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 3.27e-04 | 190 | 204 | 8 | 5223_DN | |
| Drug | Lidocaone hydrochloride [73-78-9]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 3.27e-04 | 190 | 204 | 8 | 4421_DN | |
| Drug | (+,-)-Synephrine [94-07-5]; Up 200; 24uM; HL60; HT_HG-U133A | 3.27e-04 | 190 | 204 | 8 | 6156_UP | |
| Drug | Diphenhydramine hydrochloride [147-24-0]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 3.39e-04 | 191 | 204 | 8 | 6020_DN | |
| Drug | Methamphetamine | SRRM1 SLK ATP6V0A1 SPTAN1 GAS8 SFI1 PTEN ADCY6 GJA5 RBM25 SCN5A MICAL3 MICAL1 HTR1A DUSP5 SH3GL1 UBR4 XBP1 USH1C CREM OPRM1 PPP3CB MACF1 SMARCD3 ARHGEF2 HES5 | 3.44e-04 | 1401 | 204 | 26 | ctd:D008694 |
| Drug | Pindolol [13523-86-9]; Down 200; 16.2uM; PC3; HT_HG-U133A | 3.51e-04 | 192 | 204 | 8 | 4496_DN | |
| Drug | 5155877; Up 200; 10uM; MCF7; HT_HG-U133A | 3.51e-04 | 192 | 204 | 8 | 6574_UP | |
| Drug | Securinine [5610-40-2]; Up 200; 18.4uM; MCF7; HT_HG-U133A | 3.51e-04 | 192 | 204 | 8 | 3470_UP | |
| Disease | Coffin-Lowry syndrome (implicated_via_orthology) | 2.05e-09 | 4 | 200 | 4 | DOID:3783 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | MYH9 SPTAN1 RPS6KA3 MRPL19 COLGALT2 PTEN RGL1 BRCA2 OTOF TIMELESS MED12 PDZD4 MICAL1 COL19A1 KALRN UBR4 XBP1 NSMCE2 CLASRP EEF2 SLC8A3 SMARCD1 MACF1 | 1.21e-06 | 1074 | 200 | 23 | C0006142 |
| Disease | Mental Retardation, X-Linked 1 | 2.36e-06 | 32 | 200 | 5 | C2931498 | |
| Disease | Intellectual Disability | ZMYND11 TRIO PTEN CACNA1G NKAP GNAS TET3 MAP7D3 PTPN23 KIF7 SMARCD1 MACF1 STAG2 | 1.27e-05 | 447 | 200 | 13 | C3714756 |
| Disease | Drug habituation | 1.40e-05 | 115 | 200 | 7 | C0013170 | |
| Disease | Drug abuse | 1.40e-05 | 115 | 200 | 7 | C0013146 | |
| Disease | Prescription Drug Abuse | 1.40e-05 | 115 | 200 | 7 | C4316881 | |
| Disease | Substance-Related Disorders | 1.40e-05 | 115 | 200 | 7 | C0236969 | |
| Disease | Drug Use Disorders | 1.40e-05 | 115 | 200 | 7 | C0013222 | |
| Disease | Drug Dependence | 1.40e-05 | 115 | 200 | 7 | C1510472 | |
| Disease | Substance Dependence | 1.40e-05 | 115 | 200 | 7 | C0038580 | |
| Disease | Substance Use Disorders | 1.40e-05 | 115 | 200 | 7 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 1.40e-05 | 115 | 200 | 7 | C0029231 | |
| Disease | Substance abuse problem | 1.48e-05 | 116 | 200 | 7 | C0740858 | |
| Disease | Coffin-Siris syndrome (implicated_via_orthology) | 2.50e-05 | 9 | 200 | 3 | DOID:1925 (implicated_via_orthology) | |
| Disease | ATRIAL STANDSTILL 1 | 4.57e-05 | 2 | 200 | 2 | C4551959 | |
| Disease | brain ischemia (biomarker_via_orthology) | 7.06e-05 | 102 | 200 | 6 | DOID:2316 (biomarker_via_orthology) | |
| Disease | cardiomyopathy (implicated_via_orthology) | 1.23e-04 | 71 | 200 | 5 | DOID:0050700 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 1.31e-04 | 15 | 200 | 3 | DOID:0050646 (implicated_via_orthology) | |
| Disease | CARDIOMYOPATHY, FAMILIAL, WITH CONDUCTION DISTURBANCE | 1.37e-04 | 3 | 200 | 2 | C1838539 | |
| Disease | Lujan Fryns syndrome | 1.37e-04 | 3 | 200 | 2 | C0796022 | |
| Disease | Myeloid Leukemia | 2.32e-04 | 18 | 200 | 3 | C0023470 | |
| Disease | Leukemia, Monocytic, Chronic | 2.32e-04 | 18 | 200 | 3 | C0023466 | |
| Disease | neuromuscular disease (implicated_via_orthology) | 2.72e-04 | 4 | 200 | 2 | DOID:440 (implicated_via_orthology) | |
| Disease | sleep duration, low density lipoprotein cholesterol measurement | 3.95e-04 | 91 | 200 | 5 | EFO_0004611, EFO_0005271 | |
| Disease | Bipolar Disorder | PDE9A RPS6KA2 ITIH1 BRCA2 TIMELESS PLCG1 DNAH8 HTR1A XBP1 CREB1 PPP3CC | 4.42e-04 | 477 | 200 | 11 | C0005586 |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 4.63e-04 | 53 | 200 | 4 | C4707243 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 4.79e-04 | 145 | 200 | 6 | DOID:1289 (implicated_via_orthology) | |
| Disease | hematocrit | SRRM1 MYH9 PDE9A DHX38 HLF GJA5 FBXO22 HOXD10 KALRN WNT7B SH3GL1 DNAH2 XBP1 USP37 OR10AD1 SMARCD3 HCRTR2 | 5.61e-04 | 1011 | 200 | 17 | EFO_0004348 |
| Disease | 3-hydroxybutyrate measurement | 6.32e-04 | 25 | 200 | 3 | EFO_0010982 | |
| Disease | brain disease (implicated_via_orthology) | 6.74e-04 | 6 | 200 | 2 | DOID:936 (implicated_via_orthology) | |
| Disease | Digitotalar Dysmorphism | 6.74e-04 | 6 | 200 | 2 | C1852085 | |
| Disease | Cornelia de Lange syndrome (implicated_via_orthology) | 6.74e-04 | 6 | 200 | 2 | DOID:11725 (implicated_via_orthology) | |
| Disease | ARTHROGRYPOSIS, DISTAL, TYPE 1 | 6.74e-04 | 6 | 200 | 2 | C0220662 | |
| Disease | acute lymphoblastic leukemia (implicated_via_orthology) | 6.74e-04 | 6 | 200 | 2 | DOID:9952 (implicated_via_orthology) | |
| Disease | Seizures | 7.48e-04 | 218 | 200 | 7 | C0036572 | |
| Disease | Sezary Syndrome | 7.96e-04 | 27 | 200 | 3 | C0036920 | |
| Disease | Morphine Abuse | 9.39e-04 | 7 | 200 | 2 | C0600272 | |
| Disease | Depression, Postpartum | 9.39e-04 | 7 | 200 | 2 | C0221074 | |
| Disease | Morphine Dependence | 9.39e-04 | 7 | 200 | 2 | C0026552 | |
| Disease | forced expiratory volume | RPS6KA1 TRAIP SNX13 CABLES1 ASCC2 MICAL3 MICAL1 TASP1 SKI MED15 DMRT2 WDR11 ERCC6L2 MYBPC1 | 1.04e-03 | 789 | 200 | 14 | EFO_0004314 |
| Disease | Primary familial dilated cardiomyopathy | 1.09e-03 | 30 | 200 | 3 | cv:C0340427 | |
| Disease | MYELODYSPLASTIC SYNDROME | 1.12e-03 | 67 | 200 | 4 | C3463824 | |
| Disease | lung adenocarcinoma | 1.24e-03 | 174 | 200 | 6 | EFO_0000571 | |
| Disease | holoprosencephaly (is_implicated_in) | 1.25e-03 | 8 | 200 | 2 | DOID:4621 (is_implicated_in) | |
| Disease | Nonorganic psychosis | 1.26e-03 | 69 | 200 | 4 | C0349204 | |
| Disease | Primary dilated cardiomyopathy | 1.57e-03 | 34 | 200 | 3 | cv:C0007193 | |
| Disease | Distal arthrogryposis | 1.59e-03 | 9 | 200 | 2 | cv:C0265213 | |
| Disease | spinal muscular atrophy (implicated_via_orthology) | 1.59e-03 | 9 | 200 | 2 | DOID:12377 (implicated_via_orthology) | |
| Disease | Malignant tumor of prostate | 1.59e-03 | 9 | 200 | 2 | cv:C0376358 | |
| Disease | cystatin C measurement | 1.78e-03 | 402 | 200 | 9 | EFO_0004617 | |
| Disease | Mental Depression | 1.81e-03 | 254 | 200 | 7 | C0011570 | |
| Disease | schizophrenia (is_implicated_in) | 1.98e-03 | 78 | 200 | 4 | DOID:5419 (is_implicated_in) | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 1.98e-03 | 10 | 200 | 2 | DOID:0111269 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 1.98e-03 | 10 | 200 | 2 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 1.98e-03 | 10 | 200 | 2 | DOID:0111596 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 1.98e-03 | 10 | 200 | 2 | DOID:0110454 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 1.98e-03 | 10 | 200 | 2 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 1.98e-03 | 10 | 200 | 2 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 1.98e-03 | 10 | 200 | 2 | DOID:0111605 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 1.98e-03 | 10 | 200 | 2 | DOID:0080326 (implicated_via_orthology) | |
| Disease | Global developmental delay | 2.17e-03 | 133 | 200 | 5 | C0557874 | |
| Disease | Macrocephaly | 2.42e-03 | 11 | 200 | 2 | C0221355 | |
| Disease | Long QT Syndrome | 2.42e-03 | 11 | 200 | 2 | C0023976 | |
| Disease | Cutaneous Melanoma | 2.71e-03 | 41 | 200 | 3 | C0151779 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 2.71e-03 | 41 | 200 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 2.71e-03 | 41 | 200 | 3 | C0858252 | |
| Disease | interleukin 2 measurement | 2.71e-03 | 41 | 200 | 3 | EFO_0008331 | |
| Disease | motor neuron disease (implicated_via_orthology) | 2.89e-03 | 12 | 200 | 2 | DOID:231 (implicated_via_orthology) | |
| Disease | distal myopathy (implicated_via_orthology) | 2.89e-03 | 12 | 200 | 2 | DOID:11720 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 2.89e-03 | 12 | 200 | 2 | DOID:2106 (implicated_via_orthology) | |
| Disease | high grade glioma (is_implicated_in) | 2.90e-03 | 42 | 200 | 3 | DOID:3070 (is_implicated_in) | |
| Disease | Schizophrenia | ABCA1 ITIH1 GCLC GNAS MED12 HTR1A XBP1 GRIA4 CREB1 OPRM1 MED15 PPP3CC WDR11 MARK2 | 2.93e-03 | 883 | 200 | 14 | C0036341 |
| Disease | Glioma | 2.94e-03 | 87 | 200 | 4 | C0017638 | |
| Disease | ejection fraction measurement | 3.10e-03 | 43 | 200 | 3 | EFO_0005527 | |
| Disease | immunoglobulin isotype switching measurement | 3.31e-03 | 44 | 200 | 3 | EFO_0010128 | |
| Disease | schizophrenia (is_marker_for) | 3.31e-03 | 44 | 200 | 3 | DOID:5419 (is_marker_for) | |
| Disease | Familial dilated cardiomyopathy | 3.31e-03 | 44 | 200 | 3 | C0340427 | |
| Disease | Alzheimer disease, cognitive decline measurement, Cognitive impairment | 3.39e-03 | 13 | 200 | 2 | EFO_0007710, HP_0100543, MONDO_0004975 | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 3.39e-03 | 13 | 200 | 2 | DOID:397 (implicated_via_orthology) | |
| Disease | Depressive disorder | 3.70e-03 | 289 | 200 | 7 | C0011581 | |
| Disease | familial atrial fibrillation (is_implicated_in) | 3.94e-03 | 14 | 200 | 2 | DOID:0050650 (is_implicated_in) | |
| Disease | Hereditary Breast and Ovarian Cancer Syndrome | 3.94e-03 | 14 | 200 | 2 | C0677776 | |
| Disease | Cardiomyopathy | 3.99e-03 | 47 | 200 | 3 | cv:C0878544 | |
| Disease | colorectal cancer (is_marker_for) | 4.42e-03 | 157 | 200 | 5 | DOID:9256 (is_marker_for) | |
| Disease | hearing impairment | 4.51e-03 | 98 | 200 | 4 | C1384666 | |
| Disease | Adenoid Cystic Carcinoma | 4.84e-03 | 100 | 200 | 4 | C0010606 | |
| Disease | Generalized seizures | 5.01e-03 | 101 | 200 | 4 | C0234533 | |
| Disease | Clonic Seizures | 5.01e-03 | 101 | 200 | 4 | C0234535 | |
| Disease | Convulsive Seizures | 5.01e-03 | 101 | 200 | 4 | C0751494 | |
| Disease | Seizures, Sensory | 5.01e-03 | 101 | 200 | 4 | C0751496 | |
| Disease | Non-epileptic convulsion | 5.01e-03 | 101 | 200 | 4 | C0751056 | |
| Disease | Psychotic Disorders | 5.01e-03 | 101 | 200 | 4 | C0033975 | |
| Disease | Atonic Absence Seizures | 5.01e-03 | 101 | 200 | 4 | C0751123 | |
| Disease | Complex partial seizures | 5.01e-03 | 101 | 200 | 4 | C0149958 | |
| Disease | Single Seizure | 5.01e-03 | 101 | 200 | 4 | C0751110 | |
| Disease | Nonepileptic Seizures | 5.01e-03 | 101 | 200 | 4 | C3495874 | |
| Disease | Visual seizure | 5.01e-03 | 101 | 200 | 4 | C0270824 | |
| Disease | Epileptic drop attack | 5.01e-03 | 101 | 200 | 4 | C0270846 | |
| Disease | Vertiginous seizure | 5.01e-03 | 101 | 200 | 4 | C0422855 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EMERQRRKEIAQKAA | 336 | Q9Y6N9 | |
| LDARDLEMSKKVRRS | 131 | Q96FF9 | |
| REVQRAMKLLDARNK | 81 | O15444 | |
| LTQKRREALERMEKL | 496 | P35609 | |
| RKMFTLLDVVNRKAR | 491 | Q6UVK1 | |
| KMERVLEDRLQDRSK | 766 | Q8N5R6 | |
| EEKAMLAKLQRTRAN | 561 | O43306 | |
| EARKVKSGIRQMRLF | 81 | Q6P6C2 | |
| RRIKMELQQKDRALV | 591 | Q92974 | |
| REKAEARRMAFLAKK | 686 | Q9H1I8 | |
| RQERTHALKTKERMA | 141 | Q9H201 | |
| KLAAAERVLRSNMDI | 221 | O95477 | |
| VRRRDMVEAAKKNLG | 81 | A7E2U8 | |
| LDKAMRNKLEGEIRR | 496 | Q8IY63 | |
| DAMIKVLQQRSRKDA | 766 | Q8IY63 | |
| DFNSTRKRMSVLVRK | 636 | O60423 | |
| KRREMEEKTRRAKLA | 1011 | O60879 | |
| LQAEIKMLSDRKREL | 251 | Q6ZP65 | |
| AQRKKEEMNRIRTLV | 256 | Q99543 | |
| KIREERRNKLAAEMG | 701 | Q96MT7 | |
| RRDNMKEKLRLKNVS | 181 | Q9H0I3 | |
| REKILNADLEKSIRM | 326 | Q9H0I3 | |
| RREMAKEAKRLKEFL | 486 | P49756 | |
| SALQKRLRDREKEME | 516 | P49756 | |
| KREARLDKVLSDMKR | 196 | Q9BTK6 | |
| EQKRISKSDMSRLRL | 876 | Q29RF7 | |
| KAKMRAAELALRSFV | 176 | Q9NS39 | |
| RKKNSMEEQVKLRSR | 731 | Q9NZL6 | |
| ERKRLQRVMTKALDH | 306 | A0A1B0GVH7 | |
| MSDLRRKRTAHERAK | 326 | Q96HW7 | |
| DEERKLLVDQMRKRS | 471 | Q75QN2 | |
| KSDVDLMRTKLRRLE | 161 | Q6IPM2 | |
| LKRILAKVQEMRDQR | 556 | Q9H3S7 | |
| KVKQLRNRADEDARM | 406 | Q92621 | |
| KAAKEAQEMRRLQLR | 756 | Q9ULE6 | |
| KSRKLHELTVMQDRR | 761 | P33176 | |
| MSVQRRRKASEREKL | 121 | A6NI15 | |
| KRARKRTSMETALAL | 121 | Q8NEZ5 | |
| KEIKEAMVRALGRTR | 296 | Q8NGE0 | |
| MLSGSKEKDRNLRRI | 266 | P35372 | |
| KEKDRNLRRITRMVL | 271 | P35372 | |
| KVRAQSRDKQIEERM | 221 | O95251 | |
| AMAVKRDSRKALVAQ | 2161 | Q14667 | |
| RMRAREKSVKSQALR | 1596 | Q7RTP6 | |
| LARAKEALQAMKADR | 131 | Q674X7 | |
| KDAIAQAEMDLKRLR | 321 | Q8NE86 | |
| RSVRDIRKSMKNDAR | 496 | Q6P0N0 | |
| KRLEEIMKRTRRTEA | 601 | Q14244 | |
| QSRRHLSAKERREMK | 811 | O60524 | |
| AKRMKVDREERANLS | 576 | P19827 | |
| ERKKAKAAMASLVRR | 871 | Q6PRD1 | |
| EMARKRLEKDLQAAR | 371 | Q8IX03 | |
| ARSMKHALREIKIIR | 56 | P31152 | |
| QAAMLRKDKEGAALR | 1071 | Q9BQS8 | |
| MRRKEKRLLQAVALV | 1 | Q86SR1 | |
| TLKVRDRVRTKMERD | 106 | P51812 | |
| KLRREKGILARSMAN | 661 | Q5T655 | |
| IMRQARVKRTDLDKA | 616 | O60318 | |
| IRREKEKEIARLRAM | 361 | Q9UL16 | |
| RKKMETEAELRKSRL | 411 | Q9UL16 | |
| MERSEKAKQLRALRK | 161 | Q99848 | |
| RMKLTFSEAIRNKAR | 846 | P48058 | |
| RKKQADTKRMVDILR | 306 | Q8N8D1 | |
| DVKNAMRKLFRVKRS | 291 | Q8NGB4 | |
| IRSRNDAIRLKKKME | 1611 | Q9UKX2 | |
| LKARALKIREERSGM | 646 | Q76G19 | |
| KKMREELAARSSRTN | 206 | O76083 | |
| ALRNAKDDRKIMQVT | 1711 | Q96JB1 | |
| MEKKRRARINVSLEQ | 1 | Q5TGS1 | |
| RMLQERKAAKEAAAA | 156 | O96000 | |
| EANMRKRRKEATSIL | 121 | P48506 | |
| LRMRKRAEVENTGKN | 2406 | O60229 | |
| ATQMKLKRARLADDL | 116 | Q9ULH7 | |
| EDAIVRMIESRQKRK | 191 | Q96MF7 | |
| TEQKRRLEAEMSKRQ | 846 | Q2M1P5 | |
| RQKLVSQIEDAMRKA | 16 | Q96RN5 | |
| KLRKTEALRMEREAL | 461 | O43896 | |
| RKRKLNMDSKERLDQ | 6 | Q8NA19 | |
| RAMVVAKLLEKRQAE | 521 | Q93074 | |
| RTLLRRAKEEEMKRF | 911 | Q8TDZ2 | |
| SLKVRDRVRTKMERD | 111 | Q9UK32 | |
| ERKQRSMAVAARKKL | 1601 | P35579 | |
| FKNAERMLRVRSLDK | 371 | Q8N159 | |
| LKKMNRENRIRELTA | 391 | P31260 | |
| NMAAKRSRDARRLKE | 236 | Q16534 | |
| NRAIKAAKSARDLDM | 151 | Q96RD7 | |
| KAMLNEVEKRRSLLE | 4951 | Q9UPN3 | |
| QKLRTKAMARRVLAG | 126 | Q15722 | |
| KRQEALVRRMAKARA | 901 | Q9NY74 | |
| RQRLMNKEKDRFASA | 496 | Q8N3R9 | |
| AEIKQIRARRKTARM | 291 | O43614 | |
| LSFLKNKQRMREEKR | 201 | Q9BZI7 | |
| ARQEDSKELRALRKM | 316 | Q8NA61 | |
| RTKLIMDEALRCKTR | 261 | Q9H0H3 | |
| SDRMRKRRAFADKEL | 231 | Q9Y5R5 | |
| RSRRSAIKKIMERDD | 2666 | P51587 | |
| IRSLKREMRKLAQED | 516 | Q8TDN4 | |
| RRLEKKRRNLMLDDV | 1561 | O43497 | |
| RKRESTKMAEAIRNF | 416 | Q9Y232 | |
| SVAAMFRVRRNAKKE | 101 | Q14993 | |
| MLSLRDQRLKEKDRL | 16 | Q9Y324 | |
| MKKAEARLLEEQRRV | 261 | Q13616 | |
| RMQEKRKLREAERAK | 101 | P36382 | |
| ERRKLKREAMRAAQA | 2306 | Q9BV73 | |
| DRETAIKLMQKLADR | 81 | Q8TB45 | |
| LKKMSRENRIRELTA | 321 | P28358 | |
| ERNAEAKRKMALARE | 326 | P08908 | |
| RQELLLEFESKMRKR | 171 | Q2TAC2 | |
| ARVRDIAIMTRNIKK | 151 | Q5T2N8 | |
| EEAARKREVRLMKNR | 266 | P16220 | |
| KREVRLMKNREAARE | 271 | P16220 | |
| NRGEIACRVMRTAKK | 56 | Q96RQ3 | |
| RMKEKEARAKFRQIV | 146 | Q7KZI7 | |
| SMLKNDIKQRLARER | 61 | Q8IWC1 | |
| RGQNREKLDKMIRSA | 311 | P09914 | |
| RKKVIMRAFSREALE | 136 | O43174 | |
| VDQIRAIMDKKANIR | 6 | P13639 | |
| RSQERRLKEKVTNME | 796 | Q5M9N0 | |
| ATKRELATGRKAMQR | 356 | Q5T890 | |
| FDEIFMINLKRRKDR | 341 | Q8IYK4 | |
| RSRAKDDIKRVMAAI | 11 | Q4VC05 | |
| LAEEATRKRELRLMK | 281 | Q03060 | |
| TRKRELRLMKNREAA | 286 | Q03060 | |
| KRIRMNAALAQLREK | 3216 | Q9P225 | |
| RNKIRAIGKMARVFS | 406 | P16298 | |
| KREELSNVLAAMRKA | 86 | Q9Y3U8 | |
| AVVRMKRAGKRFEIA | 16 | Q9Y3A5 | |
| LDGRQLRKMLRKEAA | 6 | Q16690 | |
| KAEMRRKAKELQQAR | 156 | P48444 | |
| KDTERDIEMKRQLRR | 81 | P0C7A2 | |
| RKRENKILASFREMV | 391 | Q8N5F7 | |
| MLRAQVKRHTVRDKL | 811 | Q9HC10 | |
| MTAIIKEIVSRNKRR | 1 | P60484 | |
| KALQADRLARRAEML | 191 | Q8NHZ7 | |
| TLRNKDMKTAIRRLR | 281 | Q96R69 | |
| MKVLQRDAALKRAEE | 16 | Q9HCH5 | |
| KKAVTDAIMSRRAIR | 256 | Q86TM6 | |
| MKREARTIKIDRRLT | 81 | Q9Y5W8 | |
| AQVEKLARKMALRRA | 341 | A8K8P3 | |
| RKGMSKRRLQELAEL | 191 | Q9H5V9 | |
| TKVNEEVAKLRRRLM | 141 | O94972 | |
| RKELMKRRKEELAQS | 941 | Q9H2G2 | |
| LAFERKLDQTIMRKR | 151 | Q96GM5 | |
| RRAKREDLKVSIHQM | 66 | Q9BRT9 | |
| RSIEEAMNEIRAKKR | 201 | O75391 | |
| VDRIKEAVRAKNMAR | 901 | O60282 | |
| MAAERKTRLSKNLLR | 1 | Q99547 | |
| REKKAVNLERALEMA | 196 | Q9BSH4 | |
| LAEKRRQMRKEALEK | 641 | Q5JWF2 | |
| RALATKDMRKSQERS | 126 | Q96Q15 | |
| RSSLKRDMEKVERQA | 286 | Q6IQ23 | |
| SRALATKDMRKSQER | 121 | Q6P435 | |
| AMKRRVLELIQEKDR | 491 | Q6ZNE9 | |
| LAAIEKRMAEKQARG | 21 | Q14524 | |
| LAFERKLDQTIMRKR | 126 | Q6STE5 | |
| VRSRNEAIRLKKKME | 1606 | P11055 | |
| RVAAQTARDRKKARM | 81 | P17861 | |
| TARDRKKARMSELEQ | 86 | P17861 | |
| EAQNLSAMEIRKKAR | 171 | Q9NSE4 | |
| ALRERRMKVTNEDFK | 406 | P62191 | |
| KMRRDRINSSIEQLK | 26 | Q5TA89 | |
| KMKEANESRLRLKRE | 626 | P12755 | |
| ERKLDQTIARKRMEI | 166 | Q92925 | |
| EKRRRDKMNSFIDEL | 81 | O00327 | |
| ALQRMAEKKVAEVLR | 911 | Q7Z7M1 | |
| REDELRAMARKIRMK | 611 | Q8N2M8 | |
| NKMKRDSRRENSLLR | 456 | Q8WXI2 | |
| EMLQRFKDSTIKRER | 871 | A5YKK6 | |
| AMGREVNALKSKLRR | 1916 | P35749 | |
| KFQIERKDMLERRKV | 91 | P49406 | |
| MEAARTAVLRVKRKR | 1 | Q96CW6 | |
| LEDGDRQKAMKRLRV | 206 | Q9UBH6 | |
| RNKIRAIGKMARVFS | 391 | P48454 | |
| FAQIRAELMKRVRDL | 431 | Q5VXH4 | |
| LRQREMAEKKTRALQ | 256 | Q9UNS1 | |
| FVDAREIKKNARRLM | 166 | P56706 | |
| EKRMVRRIAELSRDK | 511 | Q8WYP3 | |
| KLSSREKSMQDRLRL | 286 | Q9UKI8 | |
| QILDELAEKLKRRMR | 231 | Q99961 | |
| LAEKLKRRMREASSR | 236 | Q99961 | |
| DERMLGAVQVKRRTK | 16 | Q8NFX7 | |
| SSRARKVLEERMRKQ | 511 | Q9UPR6 | |
| AKRRERMDQITAQKE | 496 | Q9UMS6 | |
| AKKDSLKARMRRISD | 371 | Q8IVF5 | |
| RLLAIVRAAFDQRMK | 401 | Q13596 | |
| RLRAENKSAVEMRKA | 221 | Q16635 | |
| RRKAEAERAQRMAKE | 366 | Q14247 | |
| ERNKMIGKRANERLE | 251 | Q8N3U4 | |
| DMNRLLKQREELTKR | 946 | Q7Z4S6 | |
| MRKAALRQITDKARE | 511 | O75533 | |
| EATKRKHQEIRAMRS | 2246 | Q13813 | |
| RAMRSQLKKIEDLGA | 2256 | Q13813 | |
| HLREKALRSMRKAQV | 886 | Q8IYB3 | |
| RKAEAARLHRQKIMA | 1021 | Q8IWV7 | |
| RNREDRISAKDLKNM | 166 | P19174 | |
| SRFAQIRAELMKKVR | 431 | O60813 | |
| RQQRKAEIMESIKRL | 496 | Q14683 | |
| IKRIIQSREREMKDL | 751 | Q14683 | |
| KLRHSEREMRNTLEK | 806 | Q9NTJ3 | |
| KAMRKVREVRAQLKD | 1036 | Q92620 | |
| EMAQKARERRAGIKT | 326 | Q13573 | |
| RKRVAAFRKNLIEMS | 366 | Q9Y5X3 | |
| AKMKQLAERARARQE | 1711 | O43151 | |
| ERGSRDKNRQVSLKM | 511 | Q8IYW5 | |
| ASRKLRINAKETMRI | 336 | Q13472 | |
| MDRKLRFVEKEIRKA | 61 | Q93050 | |
| GLLENRTEKRKRMIS | 196 | Q86T82 | |
| MARLTKRRQADTKAI | 1 | Q15326 | |
| TKQRRIRAIKEMARV | 116 | Q9P272 | |
| SLRKKQLATREAMAR | 626 | Q9BZH6 | |
| IDAARRETRAEKKRM | 4781 | Q5T4S7 | |
| LTKRMLEERNREKAE | 246 | Q92575 | |
| AERVDTDFMQLKKRR | 206 | Q9H6P5 | |
| KRKSARRKEFIMAEL | 1286 | O75962 | |
| QAQEEARRLRSKMKT | 151 | Q9BWF2 | |
| KNLRLKHTEEITRMR | 161 | O95995 | |
| LKVRDRVRTKMERDI | 101 | Q15418 | |
| ATLKVRDRVRSKMER | 96 | Q15349 | |
| EARREMARILKELKQ | 321 | P32418 | |
| ESRREMIRILKDLKQ | 311 | P57103 | |
| LKRMRREEKKSAAFA | 241 | Q00872 | |
| LERFKLRRMKANARE | 96 | Q13562 |